Next Article in Journal
Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases
Next Article in Special Issue
Semen Analysis in “Urology-Naïve” Patients: A Chance of Uroandrological Screening in Young Males
Previous Article in Journal
Increased Peritoneal Protein Loss and Diabetes: Is There a Link?
Previous Article in Special Issue
Radiation Exposure and Surgical Outcomes after Antegrade Sclerotherapy for the Treatment of Varicocele in the Paediatric Population: A Single Centre Experience
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

A Narrative Review Discussing Vasectomy-Related Impact upon the Status of Oxidative Stress and Inflammation Biomarkers and Semen Microbiota

by
Bogdan Doroftei
1,2,3,
Ovidiu-Dumitru Ilie
4,*,
Radu Maftei
1,2,3,*,
Ioana-Sadyie Scripcariu
1,2,
Theodora Armeanu
1,2,3,
Irina-Liviana Stoian
1 and
Ciprian Ilea
1,2
1
Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”, University Street no 16, 700115 Iasi, Romania
2
Clinical Hospital of Obstetrics and Gynecology “Cuza Voda”, Cuza Voda Street no 34, 700038 Iasi, Romania
3
Origyn Fertility Center, Palace Street, no 3C, 700032 Iasi, Romania
4
Department of Biology, Faculty of Biology, “Alexandru Ioan Cuza” University, Carol I Avenue no 20A, 700505 Iasi, Romania
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(7), 2671; https://doi.org/10.3390/jcm12072671
Submission received: 11 March 2023 / Revised: 27 March 2023 / Accepted: 31 March 2023 / Published: 3 April 2023
(This article belongs to the Special Issue Clinical Management of Male Infertility)

Abstract

:
Background: Male contraceptive approaches besides tubal sterilization involve vasectomy and represent the method of choice among midlife men in developing countries thanks to many advantages. However, the subsidiary consequences of this intervention are insufficiently explored since the involved mechanisms may offer insight into a much more complex picture. Methods: Thus, in this manuscript, we aimed to reunite all available data by searching three separate academic database(s) (PubMed, Web of Knowledge, and Scopus) published in the past two decades by covering the interval 2000–2023 and using a predefined set of keywords and strings involving “oxidative stress” (OS), “inflammation”, and “semen microbiota” in combination with “humans”, “rats”, and “mice”. Results: By following all evidence that fits in the pre-, post-, and vasectomy reversal (VR) stages, we identified a total of n = 210 studies from which only n = 21 were finally included following two procedures of eligibility evaluation. Conclusions: The topic surrounding this intricate landscape has created debate since the current evidence is contradictory, limited, or does not exist. Starting from this consideration, we argue that further research is mandatory to decipher how a vasectomy might disturb homeostasis.

1. Introduction

Vasectomy is an elective and relatively minor family planning (FP) contraceptive approach that implies surgical ligation and disruption of the sperm flow from the proximal to the distal end of the vas deferens, similar to tubal sterilization, but less complicated than in women. From the health payer’s perspective, this is marked by low costs, effectiveness, toleration, and simplicity. Since no absolute contraindications are postulated, the exact figures fluctuate, with approximately one hundred million interventions performed worldwide based on the available statistics [1,2,3,4].
Though it has become typical and increasingly preferred among midlife men from growing and developing countries, and has a high success rate that reaches up to 99.7% and presumably a low risk of complications, complete reconstruction of the reproductive function remains under debate [5]. Around 10% of men, who represent a small fraction in contrast with the number of procedures, might display pain, bleeding, and inflammation, with vasovasostomy retaining a patency rate from 80 to 99.5%. Thus, it reflects the interest in VR correlated to other life-related variables such as divorce or remarriage [6,7].
Irrespective of the type, subsequent investigations discuss the impact on the testes, characterized by structural damage, because a surfeit of pathologies following vasectomy has been described with the expansion of our knowledge and understanding of this topic. Therefore, as evidence materializes to complete this spectrum and overall sphere of data, distinct mechanisms proposed to explain the causality started to gain interest and promoted a tremendous body of literature [5,6,8,9].
Precisely, these revolve around the increase of anti-sperm auto-antibodies production and hydrostatic pressure, but the most important is regarding OS, mainly because of fulminant generation of both reactive oxygen species (ROS) and reactive nitrogen species (RNS) [10]. OS is defined as an imbalance between anti- and pro-oxidants, the latter being found in elevated levels under the presence of ROS, which are unstable byproducts of normal metabolism, molecules via the acquaintance of electrons from proteins, lipids, nucleic acids becoming stable and able to initiate chain reactions that can harm the cells [11,12,13,14].
Under physiological situations when the level is low to moderate, ROS fulfills crucial biological functions by maintaing the cellular homeostasis, intracellular signaling pathways regulation, and immune and mitogen responses [15]. In this context, ROS ensure sperm capacitation, hyperactivation, and fertilization properties, motility, and chemotaxis; it promotes chromatic compaction in maturing spermatozoa and acrosome reaction and oocyte interaction [10,16,17,18].
With two documented sources of endogenous ROS, particularly leukocytes and immature spermatozoa [16,19], spermatozoa are susceptible to oxidation because of a lack of cytoplasmic antioxidant enzymes and a large amount of membrane unsaturated fatty acids [20]. Consequently, an impaired sperm function due to high ROS generation causes deoxyribonucleic acid (DNA) fragmentation, lipid peroxidation, membrane integrity loss, increased permeability, reduced motility, and apoptosis [11,12,13,14,16].
Fortunately, aerobic biological organisms are equipped with an antioxidant system present in seminal plasma and spermatozoa and of which intrinsic protection is provided by intracellular non- and enzymatic antioxidants [21]. The main contributors are catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx), while non-enzymatic examples are glutathione, carnitine, carotenoids, urate, and vitamins C and E, dedicated to maintaining redox balance and to avoid injury [22].
In contrast, an altered redox status of the seminal fluid has harmful effects on sperm parameters, which may culminate in male infertility [22,23,24,25,26] and thus could explain primary and secondary infertility, which accounts for approximately 25% of all idiopathic infertility cases besides those that range from 40 to 88% [27]. Conclusively, OS mediates cell death and tissue injury since it displays a pathological role originating from intrinsic etiologies such as inflammation triggered by exogenous factors and disorders [28,29,30,31].
Unfortunately, there is a lack of consensus on whether patients should be or not be examined for OS. The type of test used, and concerns over the antioxidant therapy duration and dose on this subject have sparked several controversies over the years [32,33]. This matter should be recognized as a public crisis mainly because it affects overall health [34,35,36], quality of life (QOL) [37,38,39], and life expectancy [40,41].

2. Methodology

The structure of the present manuscript follows the work of Green et al. [42] concerning writing a narrative review.

2.1. Rationale for Considering Semen Microbiota

“Microbiome” is a term introduced by Joshua Lederberg 22 years ago [43], subsequent molecular studies mapping four major ecosystems [44], including the urogenital microbiota. More specifically, semen microbiota refers to a diverse community of microorganisms that colonize and inhabit semen and include bacteria, viruses, fungi, and protozoa [45,46]. As each individual possesses their own unique personalized profile of microorganisms, a number of factors may shape and influence the microbiome, such as age, diet, lifestyle, and sexual behavior [47]. Recent studies have shown that semen is not a sterile fluid, as was previously believed, but rather contains a complex microbial ecosystem. Thus, recent data suggest that urogenital dysbacteriosis may be associated with male infertility and other reproductive health issues [48,49].
While many consider this topic a novel field of investigation that benefits from extensive attention since seminal OS, bacteriospermia, and leukocytospermia are known to play a major role in male infertility, a significant portion of cases remain idiopathic in nature [50]. Additional studies into this area are mandatory [51], as this approach has potential despite probiotics’ lack of efficiency [52]. To better emphasize the importance of the microenvironment that reunites communities at the level of the reproductive system stands the overexpression of the S-adenosyl-L-methionine (SAM) metabolite in infertile men. Genomic alterations in SAM lead to several observations, suggesting the role in various biological processes such as OS, DNA methylation, and polyamine synthesis could ensure the bridge to decipher this intricate interconnection [53]. Considering that semen microbiota in male reproductive health is still not well understood, additional research is needed to characterize the microbiota and comprehend its influence.

2.2. Databases Searches and the Strategies Applied

All relevant information for conducting this manuscript was gathered this year between 1 January and 31 March from three academic databases, mainly PubMed, Web of Knowledge, and Scopus. We applied a controlled vocabulary to ensure optimum coverage of a significant body of literature that includes keywords targeting investigations carried out on “humans” and experimental models such as “mice” and “rats”. Irrespective of the organism, we coupled this string with “OS”, “inflammation”, and “semen microbiota”, having as a primary endpoint the associated consequences derived due to “vasectomy” with emphasis on histological alterations and biochemical and molecular changes (Figure 1).

2.3. Inclusion Criteria

Studies had to be research articles that report original data written in English, be published within the time frame 2000–2023, and describe the outcomes of all three stages of intervention (pre-, post-, and VR).

2.4. Exclusion Criteria

The following types of papers were excluded: (I) articles that report findings in another language than English and/or from another organism than those mentioned above, (II) case report, (III) case series, (IV) review, (V) systematic review, (VI) meta-analysis, (VII) letter to the editor, (VIII), editorial, (IX), correspondence, (X) opinion, (XI) response, (XII) comment, (XIII) work protocol, (XIV) trial, (XV) conference poster and/or abstract, (XVI) computational simulation, and (XVII) preprint.

2.5. Study Selection

Four independent authors (B.D., O.-D.I., T.A., and I.-L.S.) first screened the titles and abstracts of each initial study, and if considered eligible, we further proceeded with a full review of the content. Discrepancies or divergent opinions were solved by common consent between each team member who searched the studies and in parallel with the remaining three authors, R.M., I.-S.S., and C.I.

2.6. Limitations of the Study

Due to the nature of this manuscript and the desire to pursue a narrative review and the heterogeneity grade in the design and aim of studies, we were limited to a strictly objective and critical evaluation where possible to expose the main aspects surrounding this topic to offer an alternative, possibly comprehensive overview.
We identified at the initial evaluation n = 118 citations, from which n = 55 were excluded due to the following considerations: n = 32 reviews, n = 6 case reports, n = 4 articles were written in another language (n = 1 in Chinese, n = 1 in French, and n = 2 in German), n = 3 book chapters, n = 3 news, n = 2 letters, n = 2 correspondences, n = 1 editorial, n = 1 meta-analysis and n = 1 trial. From the remaining n = 63 studies, n = 32 were integrated into the “humans” studies category, whereas n = 31 were in the “mice/rats” arm.
Sequentially, from n = 32 “humans” manuscripts, n = 19 were subsequently removed due to the degree of divergence, from which only n = 13 were included. Based on the study design, n = 7 targeted OS, n = 5 inflammation, and n = 2 the semen microbiota. It should be mentioned that n = 1 contains data valuable for 2 out of 3 main subsections of this manuscript. Regarding the experimental models, we identified only n = 9 eligible studies, and n = 22 were removed due to heterogeneity between the articles. Precisely, n = 5 were oriented toward OS, n = 4 toward inflammation, and n = 0 toward the participation of the semen microbiota (Figure 2).

3. Results

3.1. Oxidative Stress

3.1.1. Humans

Zini et al. [54,55] conducted on two distinct occasions several investigations regarding the enzymatic activity of SOD and CAT in men that presented to undergo a vasectomy, post-vasectomy, or infertility evaluation. The authors demonstrate relatively similar values of SOD and CAT among the analyzed men. It can be argued that infertility might result from abnormal ROS generation rather than a defective activity of the antioxidant system. Although we cannot exclude the possibility of low semen antioxidants in subsets of patients with elevated ROS production, SOD and CAT appear to have a post-testicular origin, conferring protection to spermatozoa once in the female reproductive system. However, this raises the question of whether the antioxidant system of infertile men [54] is impaired in contrast with that of normospermic men [56,57] as an explicit diminishing in the presence of elevated ROS has not been observed. Thus, additional studies confirm a defective antioxidant system in infertile individuals [58,59]. The working protocols could play a prominent role in amplifying the risk of erroneous findings [60,61] drawn by the collection of seminal plasma and the presence of cellular debris [62], as a centrifugation speed at 400 g [63] to 700 g is insufficient.
Shortly after the observations made by Zini et al. [54,55] of a non-significant change in SOD and CAT, Pasqualotto et al. [64] extended the necessity of implementing strategies that target OS in infertile patients seeking specialty care. Not only ROS levels in the examined groups varied significantly; particularly in varicocele associated with infection, this further extrapolates to the total antioxidant capacity (TAC). ROS negatively influences sperm concentration, motility, and morphology irrespective of the clinical diagnosis, a presumably beneficial role involving the antioxidant supplements to reduce OS and improve sperm quality. The subsequent analyses suggest a notable difference in ROS, which mirrors negative correlations with sperm concentration, count, and motility in those who requested VR [64,65,66] and positive correlation with interleukin-6 (IL-6) [65] and leukocytes [66] in neat and washed semen. Cumulatively, all these changes should be confirmed in randomized controlled trials (RCTs) as possibly leading to subfertility.
A reference system development in accordance with the World Health Organization (WHO) directives by Athayde et al. [66] shows high ROS levels in non-leukocytospermic and leukocytes samples in washed and neat semen. Attempts to create a reference system led to different results because the data from Nallella et al. [67] were similar in values to those of Shekarriz et al. [68]. The optimal cutoff of 10.0 and 51.5 and the accuracy varied from 69 to 73.2% for samples with leukocytes and without leukocytospermia [66]. One major player through which can be deciphered the underlying OS action is age, considering the persistence of sperm parameters, as suggested by Cocuzza et al. [69] and by other teams [64,66]. Taken together, reference values of ROS in a fertile population can help pinpoint ROS pathologic interval. Moreover, it might pave the way for patients to benefit from antioxidant treatment in cases of delayed fatherhood or if couples with unknown causes of infertility desire to pursue assisted reproduction technology (ARTs). Although sperm concentration is a parameter that remains constant once with aging, irrespective of clinical diagnosis [64] and antioxidant enzyme activity [54], this irreversible process provokes a decrease in motility and morphology and warrants causality [64,69,70]. Varicocele associated with infection is a condition that amplifies up to fourfold ROS generation [64,71], which in part contradicts former results [69], generating elevation of lipid peroxidation [72,73] marked by inflammation and decrease of the fertilization rate [65,74].
Hypoxia in the testes activates the apoptosis process modulated by the transcriptional target of the p53 Bax gene upregulated in varicocele. In turn, this promotes the expression of hypoxia-inducible factor 1-α (HIF-1α) and of vascular endothelial growth factors (VEGF) in vascular endothelium and cytoplasm of germ cells, likely to have a paracrine effect on testicular microvasculature [75,76]. In parallel, VEGF can inhibit spermatogonial proliferation and instead enhance nitric oxide production, which perpetuate OS in varicocele individuals [77]. 4-hydroxynonenal (4-HNE) has come to attention because this aldehyde end byproduct of lipid peroxidation created during the oxidation of unsaturated fatty acids can provoke DNA damage and play a role in assembling adducts with proteins that induce apoptosis. Shiraishi et al. [78] highlight an association with the expression of p53 but that has an inverse effect with proliferating cell nuclear antigen (PCNA), spermatogonia, Sertoli cells, and primary spermatocytes. Though p53 mediates 4-HNE toxicity in varicocele and obstructive azoospermia (OA), this is only one pathway that deteriorates spermatogenesis, and the therapy may be helpful in those whom OS is responsible for subfertility [78]. Being hypothesized that OS could deteriorate in a gonadotropin-independent manner the proliferation of germ cells and implicitly spermatogonial proliferation [79] and spermatogenesis, research in the field reveals that 4-HNE-modified proteins did not act upon serum follicle stimulating hormone (FSH) nor Johnsen’s score but rather significantly on PCNA. That point sustains the idea that mitosis is susceptible to OS, as well as Sertoli cells or meiosis [78], which is in accord with another publication that did not show a relationship between serum FSH and PCNA expression [80]. Starting from that consideration, it was possible to bring into discussion the expression of p53 in association with germ cells apoptosis [81,82]. Staining protocols indicate that p53 is indeed involved in the apoptotic pathway because primary spermatocytes and spermatogonia both have been shown to be positive for p53, except bcl-2 associated X-protein (Bax) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) [82]. This further suggests a cell cycle arrest rather than apoptosis of p53 in spermatogonia.
A brief overview of the studies that comparatively discuss the effects upon OS biomarkers on human patients is detailed in Table 1.

3.1.2. Experimental Models

Liu et al. [83] detail the role of the peroxiredoxins (Prxs) family in protecting spermatozoa [84], suppressing inflammation by oxidative damage induced by H2O2 and ultraviolet radiation (UV) [85], and alleviating germ cell apoptosis and histological alterations [83]. The OS-Prx 1, 2, 3, and 6 linkage could represent the foundation for antioxidant supplements administration to reduce damage inflicted by the vasectomy to the testes and epididymis and improve the fertility rate post-VR. As an essential physiological process, apoptosis maintains testicular homeostasis while the opposing lead to germ cell death [86]. The apoptotic cells are predominantly spermatogonia and elongating spermatids [83] in rats [87] and hamsters [88]. With degeneration of the seminiferous tubule that progresses in a time-dependent manner post-vasectomy, it may advance to more severe cases on days 15–30. A documented reduction in the number of spermatids and spermatocytes in mice [83,89] in week 5 [89] and recovery at 45–120 days [83] in humans last for one to two years [90], and up to three months in rats [91].
Thiobarbituric acid reactive substances (TBARS) or forms of RNS can hamper spermatogenesis in OA per Başar et al. [92]. However, malondialdehyde (MDA) is the primary biomarker of lipid peroxidation, which bears a role in sperm fluidity, serum estradiol (E2), and progesterone (P4). The level of MDA gradually increases throughout the next couple of weeks post-vasectomy [83] and persists for half a year after tubal ligation (TL) [93].
The MDA and prooxidant-antioxidant balance (PAB) levels appear to be dependent on the point of ligation, contrary to the proximal end of the vas deferens sectioning [94], due to intra-organ hydrostatic pressure following site obstruction nearest to the ductal obstruction. Not surprisingly, the diameter testes of vasectomized rats were notably smaller, mainly when the incision was performed closest to the testis but not the contralateral testis [94,95], a description of a severe contra-lateral injury being made [96]. Mechanically speaking, ROS fulminant generation might be connected to TL-induced hypoxia in the fallopian tubes (FTs) and ovaries by slowing down the electron transmission in the mitochondria [97]. It elevates the expression of inducible nitric oxide (iNOS) and VEGF [98] since hypoxia-inducible factors (HIF-α) bind to hypoxia-sensitive regions and initiate a response either to regulate VEGF transcription or mediate HIF-α by iNOS [98].
One mg/kg melatonin intra-peritoneally (I.P.) reduces testicular damage after twelve weeks of the administration as the testicular diameter and mean seminiferous tubular diameters (MSTD) of the contralateral testis remain unaffected [94]. The antioxidant treatment could be a recommended approach prior to sperm extraction for intracytoplasmic sperm injection (ICSI) due to obstructive infertility post-VR. Analogous correlations with humans for oxidative biomarkers, sperm motility, and morphology were discovered. In cases of negative associations, but instead between TAC with sperm morphology, proposed mechanisms toward infertility pinpointed oxygen radicals generation by leukocytes, sperm damage due to epididymal blockage, and of the immune system or immature sperm [73,99].
Nevertheless, there is a lack of evidence concerning seminal plasma ROS and TAC levels’ disparity between infertile and healthy men [73], as some studies suggest between VR and donors. Some reports indicate an elevated ROS in those that underwent unilateral vasectomy, showing histological changes in ipsilateral testicular tissue [100]. This is based on the observations that there is an abundant collagen fibril accumulation and anti-vimentin antibodies in the peritubular area and within myoid cells, accompanied by intense immunoglobulin G (IgG) antibodies in both testes [101]. Despite TBRAS increased level, no gross morphological change was remarked even though in the literature the increase of superoxide radical in the granuloma side post-vasectomy was noted [102].
Gale et al. [103] demonstrate that females seek refuge when near castrated counterparts compared with healthy or vasectomized mice. They exhibit increased levels of glucocorticoids, and this avoidance behavior suggests a response to stress rather than mating behavior.
A brief overview of the studies that comparatively discuss the effects upon OS biomarkers on rats and mice is detailed in Table 2.

3.2. Inflammation

3.2.1. Humans

The physiological implication of resistin led to debate among the community. A publication from Kratzsch et al. [112] shows that adipose tissue-specific secretory factor (ADSF) positively correlates with inflammatory mediators IL-6 and elastase [113,114]. This cysteine-rich secretory protein upregulates the expression of IL-6 and leukocytes [115], with defined roles in inflammation and metabolism regardless of the semen quality [112]. The theoretical source resides within the mononuclear leukocytes [113] and Leydig cells [116]. Subsidiary data indicate a negative association with the body mass index (BMI) in non-obese patients with normal BMI [112,117] at a corresponding concentration [118], not in the pathological range for both IL-6 [119] and elastase [120].
Systemic inflammation transmission in obese patients with metabolic syndrome (MetS) recently brought forward the possibility of elucidating the impact on semen and the genital tract. Though Pilatz et al. [121] noted an increase of C-reactive protein (CRP), IL-6, and interleukin-10 (IL-10) by coverage of insulin-dependent tissue [122], this attempt to explain the causality remains provocative. With no change in semen parameters nor systemic inflammation based on IL-6 and IL-10 [121], data confirm numerous studies on the increase of circulating biomarkers [123,124,125,126,127,128,129] and have to do with ethnicity [130], gender [124], sample size [125,131], as well as definition and heterogeneity [128,131].
With a seminal cytokine concentration in the range [121] with a previous report [132] on polymorphonuclear (PMN) elastase and peroxidase-positive leukocytes [133,134], the ratio in blood and semen was comparable with the spectra of those with human immunodeficiency virus (HIV) [135]. The observed inflammation did not impact standard pointers of seminal tract inflammation. As BMI is not equivalent to MetS [134,136,137], the semen parameters and concentrations are constant, instead causing a decrease [134], and impact motility [134,138] and morphology [137] by amplifying the risk for oligozoospermia or azoospermia [139,140] in morbidly obese men.
Chemokine (C-C motif) ligand 20 (CCL20), chemokine (C-C motif) ligand 28 (CCL28), the glutamic acid-leucine-arginine (ELR) motif-negative MIG-chemokine (C-X-C motif) ligand 9 (CXCL9) [141,142,143] and more recently granulocyte chemotactic protein 2 (GCP-2)/chemokine (C-X-C motif) ligand 6 (CXCL6) [144] suggest that inflammation of the pharyngeal epithelial cells possess antimicrobial activity that is regulated by MIG/CXCL9 [145], both being synthesized in the male reproductive tract alongside ELR-negative/positive CXC chemokines [146]. Collin et al. [147] report antithetical levels of GCP-2/CXCL6 between healthy donors and vasectomized men in seminal plasma, which may offer support for those who desire elective sterilization. Conclusively, GCP-2/CXCL6 confers protection against the urogenital pathogen Neisseria gonorrhoeae or commensal gut bacteria Enterococcus faecalis by activating nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and downstream inflammatory stimuli as lipopolysaccharides (LPS), tumor necrosis factor-α (TNF-α), and interleukin-1β (IL-1β) [148]. There are organs whose epithelial cells’ GCP-2/CXCL6 are expressed during inflammation such as gastrointestinal epithelial, airway, or pharyngeal cells [148,149,150,151,152,153].
Belardin et al. [154] spotlighted a couple of months ago the limited knowledge regarding the purinergic signaling in the ductus efferentes. Damage-associated molecular patterns (DAMPs), including adenosine 5′-triphosphate (ATP) and uracil-diphosphate glucose (UDP)-glucose that initiates P2T14 localized in the apical membrane of epididymal epithelial cells, is triggered in inflammatory conditions if the germ cells are damaged. Independently of the pro-inflammatory receptor P2Y14′ expression in the proximal regions of ciliated cells and distal parts of unidentified epithelial cells, P2Y14 expression was further reported in a subpopulation of clear cells (CC), basal cells (BC), and also in principal cells from caput, epididymal, and corpus, and cauda regions. The mRNA was noted in the corpus, cauda, and principal cells (PC) of the corpus region in vasectomized men. This led to the conclusion that vasectomy causes spermatozoa congestion characterized by an inflamed-prone localized environment.
A brief overview of the studies that comparatively discuss the effects upon inflammatory biomarkers on human patients is detailed in Table 3.

3.2.2. Experimental Models

Mice immunization with viable syngeneic testicular germ cells (TGC) led to epididymitis without orchitis development, contrary to targeted experimental autoimmune orchitis (EAO). Similar to in vivo studies that involved retrograde Escherichia coli-induced epididymitis, both Qu and Turner et al. [155,156] observe in the initial segment of the epididymis lymphocytic infiltration due to obstruction of vas deferens. Responsible for this inflammatory landscape [157,158] stands the myoid and epithelial cells of the epididymis associated with the exhibition of IL-6 and IL-10 in cryptorchid crypt epididymis [159]. While IL-6 expression in VR [65] increases, in parallel with IL-10 suppress EAO development [160], it can reduce TGC-induced EAO, and triggers apoptosis of germ cells within seminiferous tubules [161], known to exert opposite effects in autoimmune diseases [162,163,164,165].
Regulatory T (Treg) cells are viewed as powerful immunosuppressive canonical tolerance-inducing entities in peripheral organs, postmeiotic and meiotic cell antigens (MGCA) gaining tolerance by the development of antigen-specific T cells, double negative T cells (TDNs). They prevent autoimmune responses that are vasectomy-related in inflamed epididymis [166,167].
Apart from regular reported inflammatory stimuli, galectin-3 is a recent protein recognized as a macrophages-secreted inflammatory factor in vasectomized mice, whose expression increases after vasectomy in 40% of testicular tissues, particularly seminiferous tubules, interstitial tissues, and tunica albuginea. Besides the inflammation, vasectomy illustrate several degenerative alterations in the number of germ and Sertoli cells in contrast with sham-operated subjects, leading to the conclusion that vasecotmy induce chronic complications and infertility post-vasovasostomy per Kashani et al. [168].
a2NTD is a pivotal portion of the a2V protein at the N-terminal released from activated monocyte and secrete cytokines [169]. According to Jaiswal et al. [170], the protein ATPase H+ transporting V0 subunit A2 called Atp6v0a2 plays a crucial role in pregnancy which is not detected in caudal epididymis of non-capacitated spermatozoa but of capacitated murine and highly expressed in the acrosomal region. Throughout the peri-implantation, decidual macrophages that possess a high degree of plasticity vary depending on the gestation age and ensure changes in phenotype(s) replying to inflammatory responses, including leukemia inhibitory factor (LIF) and interleukins (IL-1β), and display polarization which is skewed toward M1 traits. However, the shifting into a mixed M1/M2 population types persist until mid-pregnancy after placental development to prevent rejection and impact parturition is promoted when the extravillous trophoblasts invade and attach to the uterine stroma and settle in the endometrial lining. In short, vasectomy may prevent further histological alterations and inflammation in experimental epididymitis. However, inflammation is a response initiated either by the autoreactive lymphocytes when gaining the access to TGC autoantigens against autoantigens of mature spermatids or localized in the preimplantation uterus by the influx of macrophages during the onset of pregnancy that may culminate in a successful pregnancy outcome.
The Hedgehog signaling pathway is essential in the epithelial-mesenchymal (Müllerian duct) communication, oviductal coiling, and uterine gland formation that interplays with Wnt 4 and Wnt 5 and homeobox A13 (HOXA13) signaling. In the female reproductive tract’s FT, no noticeable signs of masculinization and regular regression of the mesonephric duct in Amhr2cre/+SmoM2 female mice were seen [171]. RNASE9 that resides within the cells in the proximal caput is not expressed in the cauda but rather in the sperm from the caput and corpus of males [172]. Around sixty-nine seminal fluid proteins (sfps) were identified after mating [173], macrophage population in the corpus luteum (CL) fulfilling an essential part in inflammatory and immune shield throughout sperm migration in the female tract [174]. The eventual depletion of host macrophages hampers Chlamydia muridarum dissemination. Even though it is a non-motile bacterium, it still invades testicular cell populations targeting Sertoli/Leydig and spermatogenic cells through the penile urethra [175]. As expected, the remarks made in the case of human patients apply to rodents as well. Seminal obstruction, regardless of the testes and side, reduces the rate of spermatogenesis, concluding that unilateral vasectomy induces vast histological changes that cover unilateral obstruction, intratubular germ cell necrosis, and an increase in tubular pressure probably linked to autoimmune responses [176].
A brief overview of the studies that comparatively discuss the effects upon inflammatory biomarkers on rats and mice is detailed in Table 4.

3.3. Seminal Microbiota

Humans

Irrespective of age, eating habits may disturb the microbial niches, particularly seminal microbiota. The so-called dysbiosis is a deleterious phenomenon that inflicts changes in the proportion of microbial communities diminishing core taxa. Owing to the fact that the underlying role of semen microbiota in infertility is obscure, Lundy et al. [53] conducted a pilot study to identify distinct bacterial signatures between non- and vasectomized men. The sequencing of the 16S ribosomal RNA (rRNA) of specific biological samples revealed a 2.3% similarity between the rectal swabs, semen, and urine samples. A 10% in terms of taxa ratio between the urine and semen among healthy individuals was also identified. In addition to the increase in α-diversity regarded as the diversity of species within a single sample or environment, the β-diversity refers to the differences in microbial community composition between multiple samples or microenvironments indicate disproportionality and marks a decrease of Collinsella and Staphylococcus after vasectomy. The rectum samples were populated by Lachnospiraceae, Collinsella, and Coprococcus, coupled with a reduction of Anaerococcus in infertile men. Conversely, Anaerococcus in the urine was increased, with a decrease of Collinsella and Aerococcus increment in semen of infertile men. Their work and results are consistent with previous studies that suggest a rich microbiome in both semen [177,178,179,180] and voided urine [181,182] with a global diversity shaped in a sex-dependent manner [177,183] and personalized profiles between the sites similar to what has been already sought in females [184]. Although shown to be depleted following a vasectomy, phylum Firmicutes, and Actinobacteria were identified in the testes of azoospermic men [185]. In this way, this completes the sphere concerning the inverse association between semen quality and Prevotella [180,186] and the presence of Aerococcus as a uropathogen in the semen of infertile men [53,177].
In a second pilot study conducted by Arbelaez et al. [187], they brought strong evidence of the decreasing α-diversity caused by vasectomy. There were identified changes in the Paracoccus, Sphingomonas, and Brevundimonas as they decreased following a vasectomy, while the abundance of Corynebacterium increased. This study reveals an increase in Proteobacteria, Actinobacteria, Bacteroidetes, and Firmicutes [185,187,188] and a decrease in the α-diversity with a particular accent on the operational taxonomic units (OTUs) and Hill1 diversity, which might be explained by the lack of testicular/epididymal microbial niche [189]. Nonetheless, an increase in Actinobacteria is documented in those with idiopathic nonobstructive azoospermia (NOA) [185,187], while semen samples tested both negative in three out of five and positive in five out of five before and after vasectomy [190].
As a concluding remark, both these authors discuss the necessity of additional and comprehensive investigations as conflicting results in terms of α-diversity are given. Until that point, the limitations of these studies are the relatively small sample size and ethnic diversity for which additional longitudinal studies could elucidate the causality. A brief overview of all changes that were noted among microbial ratio at the level of semen can be found in Table 5.

4. Discussion

Infertility evolved into a profound issue in many countries affecting a significant proportion of individuals of both sexes as the popularity of ART procedures matures and tries to meet the requests. As far as it goes for men, many non(reproductive) disorders and treatments might stand behind this, while a fraction of cases remain unexplained and, thus, a thorough evaluation could guide the clinicians to treatable causes and allow natural fertility [191,192].
The popularity of microsurgical reconstruction has increased over the years among men who undergo a vasectomy as it is more cost-effective compared with in vitro fertilization (IVF) and ICSI or sperm retrieval [193]. However, conditions in such cases are that vasectomy was performed less than fifteen years prior and there are no female risk factors, as female age and obstruction epididymal are of interest, and the procedures should be individualized [194].
Varying sperm retrieval procedures are well-established to obtain spermatozoa for ICSI in infertility settings. Despite the tendency to treat azoospermic patients by ICSI using surgically retrieved sperm, vasovasostomy remains the gold standard. The current technology ensures spermatozoa recovery in approximately half of the patients with NOA. Otherwise they can be relatively easily obtained by testicular sperm aspiration (TESA), percutaneous epididymal sperm aspiration (PESA), or testicular biopsy in men in OA when vasovasostomy is not recommended [195,196]. For about half of NOA in which the sperm may be obtained by testicular biopsy, there are no accurate tests to predict the recovery rate, which is otherwise limited and the chance to establish an ongoing pregnancy as well is decreased relative to those with normal spermatogenesis [197].
Reports indicate that repeated PESA punctures (up to five) with a 25G needle induce a cumulative effect dependent on the number of sessions. This is characterized by inflammatory and stereological alterations that reunite under local fibrosis, lymphoplasmocitary infiltrate, and volumetric enlargement of the connective tissue [198]. Post-vasectomy pain syndrome (PVPS) that reunites conditions mentioned above may be exceeded by using anti-adhesion agents that confer protection against further structural destruction post-operatively [199]. Recent advances in the field that rely on biodegradable polymer grafts offer insight and offer an effective response in reconstructing obstructed or absent vas deferens [200]. Additional screenings in the aftermath of vasectomy pinpoint at the ligation site acute inflammation and augment the expression of transferrin and osteopontin by the vas and epididymal epithelium [201]. In cases of drug-induced epididymal inflammation, this may pave the path of measuring the induction of pro-inflammatory genes [202], vasectomy leading to sperm antibodies, and sperm granuloma at least [203].
Testicular sperm extraction (TESE) for NOA and OA are also widely conducted with OA patients representing the group of good candidates for seminal reconstruction or microscopic epididymal sperm aspiration (MEA) [204]. Contrary to expectations following TESE, this indicated it would be necessary to turn to a sperm donor or adoption. As suggested, microepididymal sperm aspiration (MESA) enhances the chances of pregnancy and clinical deliveries after ICSI without testicular surgical damage [205].
ICSI using round spermatids is not a suitable option, with a means to improve the outcome consisting in in vitro cultures of immature germ cells until more advanced stages. Consequently, the low pregnancy rates reflects the need for much more safer approaches [206,207,208] and we can witness a decline in the percentages of pregnancy rates via ART. The number of spermatids, testicular abnormalities, and apoptosis of germ cells post-vasectomy may worsen with extended periods of obstruction [209] and is viewed in the pregnancy rates.
Knowing that spermatogenesis usually occurs in larger testis, a unilateral therapeutic biopsy in OA patients may be pursued if the size difference between the testes is significant [210]. A randomized clinical trial published several years ago aims to improve the outcomes following VR by using intra-operative local mitomycin-C (MMC) to prevent common sexual complications, late stricture, and obstruction. Among several advantages that refer to costs and increase in the sperm count, intra-operative MMC appears to be safe and efficient in vasovasostomy in the first five to ten years [211].
It is worth mentioning that clinical trials carried out over the years ruled out the possible increased risk of corpora amylacea (CA) [212] and atherosclerotic heart disease, despite there being remarked a significant proportion of antisperm antibodies (ASA) development after vasectomy [213]. No correlation exists between ASA and inflammatory/infectious diseases [214] in defiance of the positive detection rate of IgG and immunoglobulin A (IgA) [215].
Varicocele is a dilation of the pampiniform plexus of the spermatic cord and the most common and correctable cause of male infertility, defined by a decline in sperm production and quality [216,217]. Varicoceles presence is a pointer of high predisposition to diabetes, hyperlipidemia, and cardiovascular conditions than in those who already have undergone vasectomy [218]. From the reduction in the spermatids/Sertoli cell ratio per unit area without influencing the number of Sertoli cells [209], varicoceles negatively influence sperm parameters secondary to elevated levels of OS, fragmentation of mitochondrial, and of genomic DNA, and apoptosis to necrosis and smaller testes of the varicoceles localization side [219,220].
Multiple meta-analyses on sperm DNA fragmentation clearly show significantly elevated DNA damage [221], lower pregnancy rates, abnormal embryo evolution, and risk of recurrent pregnancy loss (RPL) as the significance of sperm DNA fragmentation (SDF) is still debatable [222,223,224]. Fortunately, surgical repair is associated with an improvement in sperm DNA and those who underwent this procedure have benefited from a low sperm DNA fragmentation [225]. DNA fragmentation is significantly higher in VR individuals without impacting spontaneous or ART pregnancy rates since there are negative correlations between DNA fragmentation index (DFI) and spermiogram [226]. Creatine kinase (CK) could be considered as an indicator of sperm quality and maturity as its level was up to 18-fold higher in the severely oligospermic group than in mild/moderate and compared with donors [227].
Recent studies demonstrated that spermiogenesis is the final stage of spermatogenesis in infertile patients with varicocele, and they are more likely to retain cytoplasmic droplets (CD). This morphologic feature related to high levels of ROS generated inside the seminiferous tubules by the CD in immature spermatozoa is involved in DNA damage [228,229]. A hypothetical mechanism originates from the overexpression of anaerobes in varicocele since both OS and leukocytospermia slightly correlate in the semen of infertile men [53,230].

5. Conclusions

Vasectomy, as we extensively discussed throughout this manuscript, can induce OS that manifests under a specific grade of inflammation and can perturb the host’s eubiosis. Although direct correlations are yet to be discovered, we tried to emphasize how impactful and deleterious such an intervention can be and in which manner it can perturb homeostasis. Unfortunately, the wider consequences of vasectomy upon an individual’s health have not been a subject intensively debated. Instead are better marked by experiments carried out in the past two decades because of numerous of the contradictions that arose and the fact that such analyses are not included in the clinical routine. In conclusion, our primary goal was to comprehensively ensure by paving the road for future studies and would be helpful to other teams conducting investigations in this context.

Author Contributions

B.D., O.-D.I., R.M., I.-S.S., T.A. and I.-L.S. (conceptualization, data curation, investigation, formal analysis, methodology, writing—original draft); B.D. and C.I. (conceptualization, methodology, supervision, validation, project administration, writing—review and editing). All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Stormont, G.; Deibert, C.M. Vasectomy. In StatPearls; StatPearls: Treasure Island, FL, USA, 2022. [Google Scholar]
  2. Zeitler, M.; Rayala, B. Outpatient Vasectomy: Safe, Reliable, and Cost-effective. Prim. Care Clin. Off. Pract. 2021, 48, 613–625. [Google Scholar] [CrossRef]
  3. Dohle, G.R.; Diemer, T.; Kopa, Z.; Krausz, C.; Giwercman, A.; Jungwirth, A. European Association of Urology Guidelines on Vasectomy. Eur. Urol. 2012, 61, 159–163. [Google Scholar] [CrossRef]
  4. Namekawa, T.; Imamoto, T.; Kato, M.; Komiya, A.; Ichikawa, T. Vasovasostomy and vasoepididymostomy: Review of the procedures, outcomes, and predictors of patency and pregnancy over the last decade. Reprod. Med. Biol. 2018, 17, 343–355. [Google Scholar] [CrossRef] [PubMed]
  5. Yang, F.; Li, J.; Dong, L.; Tan, K.; Huang, X.; Zhang, P.; Liu, X.; Chang, D.; Yu, X. Review of Vasectomy Complications and Safety Concerns. World J. Mens Health 2021, 39, 406–418. [Google Scholar] [CrossRef]
  6. Dickey, R.M.; Pastuszak, A.W.; Hakky, T.S.; Chandrashekar, A.; Ramasamy, R.; Lipshultz, L.I. The Evolution of Vasectomy Reversal. Curr. Urol. Rep. 2015, 16, 40. [Google Scholar] [CrossRef] [PubMed]
  7. Kirby, E.W.; Hockenberry, M.; Lipshultz, L.I. Vasectomy reversal: Decision making and technical innovations. Transl. Androl. Urol. 2017, 6, 753–760. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Schwarzer, J.U.; Steinfatt, H. Current status of vasectomy reversal. Nat. Rev. Urol. 2013, 10, 195–205. [Google Scholar] [CrossRef]
  9. Patel, A.P.; Smith, R.P. Vasectomy reversal: A clinical update. Asian J. Androl. 2016, 18, 365–371. [Google Scholar]
  10. Dutta, S.; Majzoub, A.; Agarwal, A. Oxidative stress and sperm function: A systematic review on evaluation and management. Arab J. Urol. 2019, 17, 87–97. [Google Scholar] [CrossRef] [Green Version]
  11. Ko, E.Y.; Sabanegh, E.S.; Agarwal, A. Male infertility testing: Reactive oxygen species and antioxidant capacity. Fertil. Steril. 2014, 102, 1518–1527. [Google Scholar] [CrossRef]
  12. Aitken, R.J.; Drevet, J.R.; Moazamian, A.; Gharagozloo, P. Male Infertility and Oxidative Stress: A Focus on the Underlying Mechanisms. Antioxidants 2022, 11, 306. [Google Scholar] [CrossRef]
  13. Bansal, A.K.; Bilaspuri, G.S. Impacts of Oxidative Stress and Antioxidants on Semen Functions. Vet. Med. Int. 2011, 2011, 686137. [Google Scholar] [CrossRef] [Green Version]
  14. Mannucci, A.; Argento, F.R.; Fini, E.; Coccia, M.E.; Taddei, N.; Becatti, M.; Fiorillo, C. The Impact of Oxidative Stress in Male Infertility. Front. Mol. Biosci. 2021, 8, 799294. [Google Scholar] [CrossRef]
  15. Kruk, J.; Aboul-Enein, H.Y.; Kładna, A.; Bowser, J.E. Oxidative stress in biological systems and its relation with pathophysiological functions: The effect of physical activity on cellular redox homeostasis. Free Radic. Res. 2019, 53, 497–521. [Google Scholar] [CrossRef]
  16. Takeshima, T.; Usui, K.; Mori, K.; Asai, T.; Yasuda, K.; Kuroda, S.; Yumura, Y. Oxidative stress and male infertility. Reprod. Med. Biol. 2021, 20, 41–52. [Google Scholar] [CrossRef] [PubMed]
  17. Ribas-Maynou, J.; Yeste, M. Oxidative Stress in Male Infertility: Causes, Effects in Assisted Reproductive Techniques, and Protective Support of Antioxidants. Biology 2020, 9, 77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Nowicka-Bauer, K.; Nixon, B. Molecular Changes Induced by Oxidative Stress that Impair Human Sperm Motility. Antioxidants 2020, 9, 134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Bisht, S.; Faiq, M.; Tolahunase, M.; Dada, R. Oxidative stress and male infertility. Nat. Rev. Urol. 2017, 14, 470–485. [Google Scholar] [CrossRef]
  20. Agarwal, A.; Majzoub, A. Laboratory tests for oxidative stress. Indian J. Urol. 2017, 33, 199–206. [Google Scholar] [CrossRef] [PubMed]
  21. Barati, E.; Nikzad, H.; Karimian, M. Oxidative stress and male infertility: Current knowledge of pathophysiology and role of antioxidant therapy in disease management. Cell. Mol. Life Sci. 2020, 77, 93–113. [Google Scholar] [CrossRef]
  22. de Ligny, W.; Smits, R.M.; Mackenzie-Proctor, R.; Jordan, V.; Fleischer, K.; de Bruin, J.P.; Showell, M.G. Antioxidants for male subfertility. Cochrane Database Syst. Rev. 2022, 5, CD007411. [Google Scholar] [CrossRef] [PubMed]
  23. Agarwal, A.; Roychoudhury, S.; Sharma, R.; Gupta, S.; Majzoub, A.; Sabanegh, E. Diagnostic application of oxidation-reduction potential assay for measurement of oxidative stress: Clinical utility in male factor infertility. Reprod. Biomed. Online 2017, 34, 48–57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Agarwal, A.; Rana, M.; Qiu, E.; AlBunni, H.; Bui, A.D.; Henkel, R. Role of oxidative stress, infection and inflammation in male infertility. Andrologia 2018, 50, e13126. [Google Scholar] [CrossRef] [PubMed]
  25. Sabeti, P.; Pourmasumi, S.; Rahiminia, T.; Akyash, F.; Talebi, A.R. Etiologies of sperm oxidative stress. Int. J. Reprod. Biomed. 2016, 14, 231–240. [Google Scholar] [CrossRef] [PubMed]
  26. Majzoub, A.; Agarwal, A. Systematic review of antioxidant types and doses in male infertility: Benefits on semen parameters, advanced sperm function, assisted reproduction and live-birth rate. Arab J. Urol. 2018, 16, 113–124. [Google Scholar] [CrossRef] [Green Version]
  27. Ritchie, C.; Ko, E.Y. Oxidative stress in the pathophysiology of male infertility. Andrologia 2021, 53, e13581. [Google Scholar] [CrossRef]
  28. Lugrin, J.; Rosenblatt-Velin, N.; Parapanov, R.; Liaudet, L. The role of oxidative stress during inflammatory processes. Biol. Chem. 2014, 395, 203–230. [Google Scholar] [CrossRef] [Green Version]
  29. Hussain, T.; Tan, B.; Yin, Y.; Blachier, F.; Tossou, M.C.B.; Rahu, N. Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxid. Med. Cell. Longev. 2016, 2016, 7432797. [Google Scholar] [CrossRef] [Green Version]
  30. Chatterjee, S. Chapter Two—Oxidative Stress, Inflammation, and Disease. In Oxidative Stress and Biomaterials; Dziubla, T., Butterfield, D.A., Eds.; Academic Press: Cambridge, MA, USA, 2016; pp. 35–58. ISBN 978-0-12-803269-5. [Google Scholar]
  31. Hussain, T.; Kandeel, M.; Metwally, E.; Murtaza, G.; Kalhoro, D.H.; Yin, Y.; Tan, B.; Chughtai, M.I.; Yaseen, A.; Afzal, A.; et al. Unraveling the harmful effect of oxidative stress on male fertility: A mechanistic insight. Front. Endocrinol. 2023, 14, 1070692. [Google Scholar] [CrossRef]
  32. Wagner, H.; Cheng, J.W.; Ko, E.Y. Role of reactive oxygen species in male infertility: An updated review of literature. Arab J. Urol. 2018, 16, 35–43. [Google Scholar] [CrossRef] [Green Version]
  33. Baskaran, S.; Finelli, R.; Agarwal, A.; Henkel, R. Reactive oxygen species in male reproduction: A boon or a bane? Andrologia 2021, 53, e13577. [Google Scholar] [CrossRef] [PubMed]
  34. Kasman, A.M.; Del Giudice, F.; Eisenberg, M.L. New insights to guide patient care: The bidirectional relationship between male infertility and male health. Fertil. Steril. 2020, 113, 469–477. [Google Scholar] [CrossRef] [PubMed]
  35. Chen, T.; Belladelli, F.; Del Giudice, F.; Eisenberg, M.L. Male fertility as a marker for health. Reprod. Biomed. Online 2022, 44, 131–144. [Google Scholar] [CrossRef] [PubMed]
  36. Murshidi, M.M.; Choy, J.T.; Eisenberg, M.L. Male Infertility and Somatic Health. Urol. Clin. N. Am. 2020, 47, 211–217. [Google Scholar] [CrossRef]
  37. de Souza, M.d.C.B.; da Silva, L.A.B.; Sequeira, F.F.; de Azevedo Antunes, R.; de Souza, M.M. The management of infertility for primary care physicians. Women Health 2023, 63, 194–203. [Google Scholar] [CrossRef]
  38. Punjani, N.; Lamb, D.J. Canary in the Coal Mine? Male Infertility as a Marker of Overall Health. Annu. Rev. Genet. 2020, 54, 465–486. [Google Scholar] [CrossRef]
  39. Alirezaei, S.; Taghipour, A.; Latifnejad Roudsari, R. The effect of infertility counseling interventions on marital and sexual satisfaction of infertile couples: A systematic review and meta-analysis. Int. J. Reprod. Biomed. 2022, 20, 795–806. [Google Scholar] [CrossRef]
  40. Choy, J.T.; Eisenberg, M.L. Comprehensive men’s health and male infertility. Transl. Androl. Urol. 2019, 9 (Suppl. 2), S239–S243. [Google Scholar] [CrossRef]
  41. Leung, A.K.; Henry, M.A.; Mehta, A. Gaps in male infertility health services research. Transl. Androl. Urol. 2018, 7, S303–S309. [Google Scholar] [CrossRef]
  42. Green, B.N.; Johnson, C.D.; Adams, A. Writing narrative literature reviews for peer-reviewed journals: Secrets of the trade. J. Chiropr. Med. 2006, 5, 101–117. [Google Scholar] [CrossRef] [Green Version]
  43. Lederberg, J.; McCray, A.T. ‘Ome Sweet ‘Omics—A Genealogical Treasury of Words. Scientist 2001, 15, 8. [Google Scholar]
  44. Turnbaugh, P.J.; Ley, R.E.; Hamady, M.; Fraser-Liggett, C.M.; Knight, R.; Gordon, J.I. The human microbiome project. Nature 2007, 449, 804–810. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Whiteside, S.A.; Razvi, H.; Dave, S.; Reid, G.; Burton, J.P. The microbiome of the urinary tract—A role beyond infection. Nat. Rev. Urol. 2015, 12, 81–90. [Google Scholar] [CrossRef] [PubMed]
  46. Murray, G.G.R.; Chaguza, C. Zooming into the structure of the microbiome. Nat. Rev. Microbiol. 2023, 21, 5. [Google Scholar] [CrossRef]
  47. Rowe, M.; Veerus, L.; Trosvik, P.; Buckling, A.; Pizzari, T. The Reproductive Microbiome: An Emerging Driver of Sexual Selection, Sexual Conflict, Mating Systems, and Reproductive Isolation. Trends Ecol. Evol. 2020, 35, 220–234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Ackerman, A.L.; Chai, T.C. The Bladder is Not Sterile: An Update on the Urinary Microbiome. Curr. Bladder Dysfunct. Rep. 2019, 14, 331–341. [Google Scholar] [CrossRef]
  49. Bae, S.; Chung, H. The Urobiome and Its Role in Overactive Bladder. Int. Neurourol. J. 2022, 26, 190–200. [Google Scholar] [CrossRef]
  50. Punab, M.; Poolamets, O.; Paju, P.; Vihljajev, V.; Pomm, K.; Ladva, R.; Korrovits, P.; Laan, M. Causes of male infertility: A 9-year prospective monocentre study on 1737 patients with reduced total sperm counts. Hum. Reprod. 2017, 32, 18–31. [Google Scholar] [CrossRef] [Green Version]
  51. Borovkova, N.; Korrovits, P.; Ausmees, K.; Türk, S.; Jõers, K.; Punab, M.; Mändar, R. Influence of sexual intercourse on genital tract microbiota in infertile couples. Anaerobe 2011, 17, 414–418. [Google Scholar] [CrossRef]
  52. Corbett, G.A.; Crosby, D.A.; McAuliffe, F.M. Probiotic therapy in couples with infertility: A systematic review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021, 256, 95–100. [Google Scholar] [CrossRef]
  53. Lundy, S.D.; Sangwan, N.; Parekh, N.V.; Selvam, M.K.P.; Gupta, S.; McCaffrey, P.; Bessoff, K.; Vala, A.; Agarwal, A.; Sabanegh, E.S.; et al. Functional and Taxonomic Dysbiosis of the Gut, Urine, and Semen Microbiomes in Male Infertility. Eur. Urol. 2021, 79, 826–836. [Google Scholar] [CrossRef] [PubMed]
  54. Zini, A.; Garrels, K.; Phang, D. Antioxidant activity in the semen of fertile and infertile men. Urology 2000, 55, 922–926. [Google Scholar] [CrossRef] [PubMed]
  55. Zini, A.; Fischer, M.; Mak, V.; Phang, D.; Jarvi, K. Catalase-like and superoxide dismutase-like activities in human seminal plasma. Urol. Res. 2002, 30, 321–323. [Google Scholar] [CrossRef]
  56. Sanocka, D.; Miesel, R.; Jedrzejczak, P.; Kurpisz, M.K. Oxidative Stress and Male Infertility. J. Androl. 1996, 17, 449–454. [Google Scholar] [CrossRef] [PubMed]
  57. Zini, A.; de Lamirande, E.; Gagnon, C. Reactive oxygen species in semen of infertile patients: Levels of superoxide dismutase- and catalase-like activities in seminal plasma and spermatozoa. Int. J. Androl. 1993, 16, 183–188. [Google Scholar] [CrossRef]
  58. Lewis, S.E.M.; Boyle, P.M.; McKinney, K.A.; Young, I.S.; Thompson, W. Total antioxidant capacity of seminal plasma is different in fertile and infertile men. Fertil. Steril. 1995, 64, 868–870. [Google Scholar] [CrossRef]
  59. Alkan, I.; Simşek, F.; Haklar, G.; Kervancioğlu, E.; Ozveri, H.; Yalçin, S.; Akdaş, A. Reactive oxygen species production by the spermatozoa of patients with idiopathic infertility: Relationship to seminal plasma antioxidants. J. Urol. 1997, 157, 140–143. [Google Scholar] [CrossRef]
  60. John Aitken, R.; Clarkson, J.S.; Fishel, S. Generation of Reactive Oxygen Species, Lipid Peroxidation, and Human Sperm Function. Biol. Reprod. 1989, 41, 183–197. [Google Scholar] [CrossRef]
  61. Aitken, J.; Fisher, H. Reactive oxygen species generation and human spermatozoa: The balance of benefit and risk. BioEssays 1994, 16, 259–267. [Google Scholar] [CrossRef]
  62. Čechová, D.; Jonáková, V. [59] Bull seminal plasma proteinase inhibitors. In Proteolytic in Enzymes, Part C.; Academic Press: Cambridge, MA, USA, 1981; Volume 80, pp. 792–803. ISBN 0076-6879. [Google Scholar]
  63. Smith, R.; Vantman, D.; Ponce, J.; Escobar, J.; Lissi, E. Andrology: Total antioxidant capacity of human seminal plasma. Hum. Reprod. 1996, 11, 1655–1660. [Google Scholar] [CrossRef] [Green Version]
  64. Pasqualotto, F.F.; Sharma, R.K.; Nelson, D.R.; Thomas, A.J., Jr.; Agarwal, A. Relationship between oxidative stress, semen characteristics, and clinical diagnosis in men undergoing infertility investigation. Fertil. Steril. 2000, 73, 459–464. [Google Scholar] [CrossRef]
  65. Nandipati, K.C.; Pasqualotto, F.F.; Thomas, A.J., Jr.; Agarwal, A. Relationship of interleukin-6 with semen characteristics and oxidative stress in vasectomy reversal patients. Andrologia 2005, 37, 131–134. [Google Scholar] [CrossRef] [PubMed]
  66. Athayde, K.S.; Cocuzza, M.; Agarwal, A.; Krajcir, N.; Lucon, A.M.; Srougi, M.; Hallak, J. Development of Normal Reference Values for Seminal Reactive Oxygen Species and Their Correlation With Leukocytes and Semen Parameters in a Fertile Population. J. Androl. 2007, 28, 613–620. [Google Scholar] [CrossRef] [PubMed]
  67. Nallella, K.P.; Sharma, R.K.; Allamaneni, S.S.R.; Agarwal, A. Identification of male factor infertility using a novel semen quality score and reactive oxygen species levels. Clinics 2005, 60, 317–324. [Google Scholar] [CrossRef] [Green Version]
  68. Shekarriz, M.; Thomas, A.J., Jr.; Agarwal, A. Incidence and level of seminal reactive oxygen species in normal men. Urology 1995, 45, 103–107. [Google Scholar] [CrossRef]
  69. Cocuzza, M.; Athayde, K.S.; Agarwal, A.; Sharma, R.; Pagani, R.; Lucon, A.M.; Srougi, M.; Hallak, J. Age-Related Increase of Reactive Oxygen Species in Neat Semen in Healthy Fertile Men. Urology 2008, 71, 490–494. [Google Scholar] [CrossRef]
  70. Group, E.C.W. Fertility and ageing. Hum. Reprod. Update 2005, 11, 261–276. [Google Scholar] [CrossRef] [Green Version]
  71. Hendin, B.N.; Kolettis, P.N.; Sharma, R.K.; Thomas, A.J.J.; Agarwal, A. Varicocele is associated with elevated spermatozoal reactive oxygen species production and diminished seminal plasma antioxidant capacity. J. Urol. 1999, 161, 1831–1834. [Google Scholar] [CrossRef]
  72. Sukcharoen, N.; Keith, J.; Stewart Irvine, D.; John Aitken, R. Predicting the fertilizing potential of human sperm suspensions in vitro: Importance of sperm morphology and leukocyte contamination. Fertil. Steril. 1995, 63, 1293–1300. [Google Scholar] [CrossRef] [PubMed]
  73. Kolettis, P.N.; Sharma, R.K.; Pasqualotto, F.F.; Nelson, D.; Thomas, A.J., Jr.; Agarwal, A. Effect of seminal oxidative stress on fertility after vasectomy reversal. Fertil. Steril. 1999, 71, 249–255. [Google Scholar] [CrossRef]
  74. Nallella, K.P.; Allamaneni, S.S.R.; Pasqualotto, F.F.; Sharma, R.K.; Thomas, A.J., Jr.; Agarwal, A. Relationship of interleukin-6 with semen characteristics and oxidative stress in patients with varicocele. Urology 2004, 64, 1010–1013. [Google Scholar] [CrossRef]
  75. Shiraishi, K.; Naito, K. Involvement of vascular endothelial growth factor on spermatogenesis in testis with varicocele. Fertil. Steril. 2008, 90, 1313–1316. [Google Scholar] [CrossRef]
  76. Shiraishi, K.; Matsuyama, H.; Takihara, H. Pathophysiology of varicocele in male infertility in the era of assisted reproductive technology. Int. J. Urol. 2012, 19, 538–550. [Google Scholar] [CrossRef]
  77. Singh, R.; Hamada, A.J.; Bukavina, L.; Agarwal, A. Physical deformities relevant to male infertility. Nat. Rev. Urol. 2012, 9, 156–174. [Google Scholar] [CrossRef]
  78. Koji, S.; Katsusuke, N. Effects of 4-Hydroxy-2-Nonenal, a Marker of Oxidative Stress, on Spermatogenesis and Expression of p53 Protein in Male Infertility. J. Urol. 2007, 178, 1012–1017. [Google Scholar] [CrossRef]
  79. Marshall, G.R.; Ramaswamy, S.; Plant, T.M. Gonadotropin-Independent Proliferation of the Pale Type A Spermatogonia in the Adult Rhesus Monkey (Macaca mulatta). Biol. Reprod. 2005, 73, 222–229. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  80. Steger, K.; Aleithe, I.; Behre, H.; Bergmann, M. The proliferation of spermatogonia in normal and pathological human seminiferous epithelium: An immunohistochemical study using monoclonal antibodies against Ki-67 protein and proliferating cell nuclear antigen. Mol. Hum. Reprod. 1998, 4, 227–233. [Google Scholar] [CrossRef] [Green Version]
  81. Beumer, T.L.; Roepers-Gajadien, H.L.; Gademan, I.S.; van Buul, P.P.W.; Gil-Gomez, G.; Rutgers, D.H.; de Rooij, D.G. The role of the tumor suppressor p53 in spermatogenesis. Cell Death Differ. 1998, 5, 669–677. [Google Scholar] [CrossRef] [Green Version]
  82. Shiraishi, K.; Naito, K.; Yoshida, K. Vasectomy impairs spermatogenesis through germ cell apoptosis mediated by the p53-Bax pathway in rats. J. Urol. 2001, 166, 1565–1571. [Google Scholar] [CrossRef] [PubMed]
  83. Juan, L.; Cheng, T.C.; Yan, L.; Xue, L.X.; Wen, T.W.; Ning, L. Vasectomy Induces Oxidative Stress and Up-Regulates the Expression of Peroxiredoxins in Mouse Testis in Short and Early Periods after Surgery. J. Urol. 2014, 191, 1920–1926. [Google Scholar] [CrossRef]
  84. Li, J.; Liu, F.; Wang, H.; Liu, X.; Liu, J.; Li, N.; Wan, F.; Wang, W.; Zhang, C.; Jin, S.; et al. Systematic mapping and functional analysis of a family of human epididymal secretory sperm-located proteins. Mol. Cell Proteom. 2010, 9, 2517–2528. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Shi, H.; Yu, H.J.; Wang, H.Y.; Wang, W.T.; Jin, S.H.; Zhu, P.; Li, S.J.; Rong, C.T.; Li, J.Y. Topical administration of peroxiredoxin-6 on the cornea suppresses inflammation and neovascularization induced by ultraviolet radiation. Investig. Ophthalmol. Vis. Sci. 2012, 53, 8016–8028. [Google Scholar] [CrossRef] [Green Version]
  86. Shukla, K.K.; Mahdi, A.A.; Rajender, S. Apoptosis, spermatogenesis and male infertility. Front. Biosci. 2012, 4, 746–754. [Google Scholar] [CrossRef] [PubMed]
  87. Shiraishi, K.; Yoshida, K.-I.; Fujimiya, T.; Naito, K. Activation of mitogen activated protein kinases and apoptosis of germ cells after vasectomy in the rat. J. Urol. 2002, 168, 1273–1278. [Google Scholar] [CrossRef]
  88. Lue, Y.; Hikim, A.P.; Wang, C.; Bonavera, J.J.; Baravarian, S.; Leung, A.; Swerdloff, R.S. Early effects of vasectomy on testicular structure and on germ cell and macrophage apoptosis in the hamster. J. Androl. 1997, 18, 166–173. [Google Scholar] [PubMed]
  89. Croft, B.T.; Bartke, A. Quantitative study of spermatogenesis in vasectomized mice. Int. J. Fertil. 1976, 21, 61–64. [Google Scholar] [PubMed]
  90. Gupta, A.S.; Kothari, L.K.; Bapna, R.B. Surgical sterilization by vasectomy and its effects on the structure and function of the testis in man. Br. J. Surg. 1975, 62, 59–63. [Google Scholar] [CrossRef] [PubMed]
  91. Ren, L.; Weng, Q.; Kishimoto, M.; Watanabe, G.; Jaroenporn, S.; Taya, K. Effect of short period vasectomy on FSH, LH, inhibin and testosterone secretions, and sperm motility in adult male rats. Exp. Anim. 2011, 60, 47–56. [Google Scholar] [CrossRef] [Green Version]
  92. Başar, M.M.; Kisa, Ü.; Tuğlu, D.; Yilmaz, E.; Başar, H.; Çağlayan, O.; Batislam, E. Testicular Nitric Oxide and Thiobarbituric Acid Reactive Substances Levels in Obstructive Azoospermia: A Possible Role in Pathophysiology of Infertility. Mediat. Inflamm. 2006, 2006, 27458. [Google Scholar] [CrossRef] [Green Version]
  93. Faramarzi, A.; Seifi, B.; Sadeghipour, H.R.; Shabanzadeh, A.; Ebrahimpoor, M. Prooxidant-antioxidant balance and malondialdehyde over time in adult rats after tubal sterilization and vasectomy. Clin. Exp. Reprod. Med. 2012, 39, 81–86. [Google Scholar] [CrossRef] [Green Version]
  94. Duru, F.I.O.; Oshiozokhai, Y.; Noronha, C.C.; Okanlawon, A. Alterations in morphometry and malondialdehyde levels in adult Sprague-Dawley rat testes in three obstructive vasectomy models: Effect of melatonin. Asian J. Pharm. Clin. Res. 2011, 4, 27–30. [Google Scholar]
  95. Altay, B.; Hekimgil, M.; KEFi, A.; Cikili, N. Histopathological examination of both ipsilateral and contralateral testes with different obstructive models in prepubertal and adult rats. BJU Int. 2001, 88, 84–89. [Google Scholar] [CrossRef] [PubMed]
  96. West, D.A.; Chehval, M.J.; Winkelmann, T.; Martin, S.A. Effect of vasovasostomy on contralateral testicular damage associated with unilateral vasectomy in mature and immature Lewis rats. Fertil. Steril. 2000, 73, 238–241. [Google Scholar] [CrossRef] [PubMed]
  97. Chandel, N.S.; McClintock, D.S.; Feliciano, C.E.; Wood, T.M.; Melendez, J.A.; Rodriguez, A.M.; Schumacker, P.T. Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α; during Hypoxia: A Mechanism of O2 Sensing. J. Biol. Chem. 2000, 275, 25130–25138. [Google Scholar] [CrossRef] [Green Version]
  98. Kilic, S.; Tasdemir, N.; Lortlar, N.; Yuksel, B.; Budak, G.; Batioglu, S. Vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS) immunoreactivities in rat ovaries and uterine tubes after tubal ligation: A controlled immunohistochemical study. Eur. J. Contracept. Reprod. Health Care 2008, 13, 431–437. [Google Scholar] [CrossRef]
  99. Shapiro, R.H.; Muller, C.H.; Chen, G.; Berger, R.E. Vasectomy reversal associated with increased reactive oxygen species production by seminal fluid leukocytes and sperm. J. Urol. 1998, 160, 1341–1346. [Google Scholar] [CrossRef] [PubMed]
  100. Aydos, K.; Kupeli, B.; Soygur, T.; Unsal, A.; Erden, E.; Tulunay, O.; Kupeli, S. Analysis of the relationship between histologic alterations and the generation of reactive oxygen species in vasectomized rat testes. Urology 1998, 51, 510–515. [Google Scholar] [CrossRef]
  101. Aydos, K.; Soygür, T.; Küpeli, B.; Ünsal, A.; Tolunay, Ö.; Erdem, E.; Güven, C.; Küpeli, S. Testicular Effects of Vasectomy in Rats: An Ultrastructural and Immunohistochemical Study. Urology 1998, 51, 1051–1056. [Google Scholar] [CrossRef]
  102. Chatterjee, S.; Rahman, M.M.; Laloraya, M.; Pradeep Kumar, G. Sperm disposal system in spermatic granuloma: A link with superoxide radicals. Int. J. Androl. 2001, 24, 278–283. [Google Scholar] [CrossRef]
  103. Gale, T.J.; Garratt, M.; Brooks, R.C. Female mice seek refuge from castrated males, but not intact or vasectomized males, mitigating a socially-induced glucocorticoid response. Physiol. Behav. 2019, 211, 112678. [Google Scholar] [CrossRef]
  104. Miranda, K.M.; Espey, M.G.; Wink, D.A. A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite. Nitric Oxide 2001, 5, 62–71. [Google Scholar] [CrossRef]
  105. Armstrong, D.; Al-Awadi, F. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic. Biol. Med. 1991, 11, 433–436. [Google Scholar] [CrossRef]
  106. Abdella, N.; al Awadi, F.; Salman, A.; Armstrong, D. Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM. Diabetes Res. 1990, 15, 173–177. [Google Scholar] [PubMed]
  107. Yagi, K. Assay for serum lipid peroxide level and its clinical significance. In Lipid Peroxides in Biology and Medicine; Academic Press: Cambridge, MA, USA, 1982. [Google Scholar]
  108. Buege, J.A.; Aust, S.D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52, 302–310. [Google Scholar] [CrossRef] [PubMed]
  109. Kei, S. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta 1978, 90, 37–43. [Google Scholar] [CrossRef]
  110. Di Monte, D.; Bellomo, G.; Thor, H.; Nicotera, P.; Orrenius, S. Menadione-induced cytotoxicity is associated with protein thiol oxidation and alteration in intracellular Ca2+ homeostasis. Arch. Biochem. Biophys. 1984, 235, 343–350. [Google Scholar] [CrossRef] [PubMed]
  111. Saville, B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 1958, 83, 670–672. [Google Scholar] [CrossRef]
  112. Kratzsch, J.; Paasch, U.; Grunewald, S.; Mueller, M.A.; Thiery, J.; Glander, H.-J. Resistin correlates with elastase and interleukin-6 in human seminal plasma. Reprod. Biomed. Online 2008, 16, 283–288. [Google Scholar] [CrossRef]
  113. Kunnari, A.; Ukkola, O.; Päivänsalo, M.; Kesäniemi, Y.A. High Plasma Resistin Level Is Associated with Enhanced Highly Sensitive C-Reactive Protein and Leukocytes. J. Clin. Endocrinol. Metab. 2006, 91, 2755–2760. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. Kaser, S.; Kaser, A.; Sandhofer, A.; Ebenbichler, C.F.; Tilg, H.; Patsch, J.R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 2003, 309, 286–290. [Google Scholar] [CrossRef]
  115. Bokarewa, M.; Nagaev, I.; Dahlberg, L.; Smith, U.; Tarkowski, A. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 2005, 174, 5789–5795. [Google Scholar] [CrossRef] [Green Version]
  116. Nogueiras, R.; Barreiro, M.L.; Caminos, J.E.; Gaytán, F.; Suominen, J.S.; Navarro, V.M.; Casanueva, F.F.; Aguilar, E.; Toppari, J.; Diéguez, C.; et al. Novel expression of resistin in rat testis: Functional role and regulation by nutritional status and hormonal factors. J. Cell Sci. 2004, 117, 3247–3257. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Utzschneider, K.M.; Carr, D.B.; Tong, J.; Wallace, T.M.; Hull, R.L.; Zraika, S.; Xiao, Q.; Mistry, J.S.; Retzlaff, B.M.; Knopp, R.H.; et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005, 48, 2330–2333. [Google Scholar] [CrossRef] [PubMed]
  118. Reilly, M.P.; Lehrke, M.; Wolfe, M.L.; Rohatgi, A.; Lazar, M.A.; Rader, D.J. Resistin Is an Inflammatory Marker of Atherosclerosis in Humans. Circulation 2005, 111, 932–939. [Google Scholar] [CrossRef] [Green Version]
  119. Eggert-Kruse, W.; Boit, R.; Rohr, G.; Aufenanger, J.; Hund, M.; Strowitzki, T. Relationship of seminal plasma interleukin (IL) -8 and IL-6 with semen quality*. Hum. Reprod. 2001, 16, 517–528. [Google Scholar] [CrossRef] [Green Version]
  120. Ludwig, M.; Kümmel, C.; Schroeder-Printzen, I.; Ringert, R.-H.; Weidner, W. Evaluation of seminal plasma parameters in patients with chronic prostatitis or leukocytospermia. Andrologia 1998, 30, 41–47. [Google Scholar] [CrossRef] [PubMed]
  121. Pilatz, A.; Hudemann, C.; Wolf, J.; Halefeld, I.; Paradowska-Dogan, A.; Schuppe, H.-C.; Hossain, H.; Jiang, Q.; Schultheiss, D.; Renz, H.; et al. Metabolic syndrome and the seminal cytokine network in morbidly obese males. Andrology 2017, 5, 23–30. [Google Scholar] [CrossRef] [Green Version]
  122. Nordestgaard, B.G.; Palmer, T.M.; Benn, M.; Zacho, J.; Tybjærg-Hansen, A.; Davey Smith, G.; Timpson, N.J. The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation Approach. PLoS Med. 2012, 9, e1001212. [Google Scholar] [CrossRef] [Green Version]
  123. Pickup, J.C.; Mattock, M.B.; Chusney, G.D.; Burt, D. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40, 1286–1292. [Google Scholar] [CrossRef] [Green Version]
  124. Saltevo, J.; Vanhala, M.; Kautiainen, H.; Kumpusalo, E.; Laakso, M. Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: A population-based study. Diabet. Med. 2008, 25, 747–750. [Google Scholar] [CrossRef]
  125. Schipper, H.S.; de Jager, W.; van Dijk, M.E.A.; Meerding, J.; Zelissen, P.M.J.; Adan, R.A.; Prakken, B.J.; Kalkhoven, E. A Multiplex Immunoassay for Human Adipokine Profiling. Clin. Chem. 2010, 56, 1320–1328. [Google Scholar] [CrossRef]
  126. Bremer, A.A.; Devaraj, S.; Afify, A.; Jialal, I. Adipose Tissue Dysregulation in Patients with Metabolic Syndrome. J. Clin. Endocrinol. Metab. 2011, 96, E1782–E1788. [Google Scholar] [CrossRef] [Green Version]
  127. Azar Sharabiani, M.T.; Vermeulen, R.; Scoccianti, C.; Hosnijeh, F.S.; Minelli, L.; Sacerdote, C.; Palli, D.; Krogh, V.; Tumino, R.; Chiodini, P.; et al. Immunologic profile of excessive body weight. Biomarkers 2011, 16, 243–251. [Google Scholar] [CrossRef]
  128. Surendar, J.; Mohan, V.; Rao, M.M.; Babu, S.; Aravindhan, V. Increased Levels of Both Th1 and Th2 Cytokines in Subjects with Metabolic Syndrome (CURES-103). Diabetes Technol. Ther. 2011, 13, 477–482. [Google Scholar] [CrossRef] [PubMed]
  129. Tisato, V.; Toffoli, B.; Monasta, L.; Bernardi, S.; Candido, R.; Zauli, G.; Secchiero, P. Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB. Clin. Nutr. 2013, 32, 259–264. [Google Scholar] [CrossRef] [PubMed]
  130. Morimoto, Y.; Conroy, S.M.; Ollberding, N.J.; Kim, Y.; Lim, U.; Cooney, R.V.; Franke, A.A.; Wilkens, L.R.; Hernandez, B.Y.; Goodman, M.T.; et al. Ethnic differences in serum adipokine and C-reactive protein levels: The multiethnic cohort. Int. J. Obes. 2014, 38, 1416–1422. [Google Scholar] [CrossRef] [Green Version]
  131. Phillips, C.M.; Perry, I.J. Does Inflammation Determine Metabolic Health Status in Obese and Nonobese Adults? J. Clin. Endocrinol. Metab. 2013, 98, E1610–E1619. [Google Scholar] [CrossRef]
  132. Politch, J.A.; Tucker, L.; Bowman, F.P.; Anderson, D.J. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum. Reprod. 2007, 22, 2928–2935. [Google Scholar] [CrossRef] [Green Version]
  133. Tunc, O.; Bakos, H.W.; Tremellen, K. Impact of body mass index on seminal oxidative stress. Andrologia 2011, 43, 121–128. [Google Scholar] [CrossRef] [PubMed]
  134. Leisegang, K.; Udodong, A.; Bouic, P.J.D.; Henkel, R.R. Effect of the metabolic syndrome on male reproductive function: A case-controlled pilot study. Andrologia 2014, 46, 167–176. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  135. Lisco, A.; Munawwar, A.; Introini, A.; Vanpouille, C.; Saba, E.; Feng, X.; Grivel, J.-C.; Singh, S.; Margolis, L. Semen of HIV-1–Infected Individuals: Local Shedding of Herpesviruses and Reprogrammed Cytokine Network. J. Infect. Dis. 2012, 205, 97–105. [Google Scholar] [CrossRef] [Green Version]
  136. Liu, M.Y.; Xydakis, A.M.; Hoogeveen, R.C.; Jones, P.H.; Smith, E.O.; Nelson, K.W.; Ballantyne, C.M. Multiplexed Analysis of Biomarkers Related to Obesity and the Metabolic Syndrome in Human Plasma, Using the Luminex-100 System. Clin. Chem. 2005, 51, 1102–1109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  137. Lotti, F.; Corona, G.; Degli Innocenti, S.; Filimberti, E.; Scognamiglio, V.; Vignozzi, L.; Forti, G.; Maggi, M. Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples. Andrology 2013, 1, 229–239. [Google Scholar] [CrossRef]
  138. Robeva, R.; Sestrimska, N.; Atanasova, I.; Mekhandzhiev, T.; Tomova, A.; Kumanov, F. Sperm disorder in males with obesity and metabolic syndrome—Pilot study. Akush. Ginekol. 2008, 47, 11–14. [Google Scholar]
  139. MacDonald, A.A.; Herbison, G.P.; Showell, M.; Farquhar, C.M. The impact of body mass index on semen parameters and reproductive hormones in human males: A systematic review with meta-analysis. Hum. Reprod. Update 2010, 16, 293–311. [Google Scholar] [CrossRef] [Green Version]
  140. Sermondade, N.; Faure, C.; Fezeu, L.; Shayeb, A.G.; Bonde, J.P.; Jensen, T.K.; Van Wely, M.; Cao, J.; Martini, A.C.; Eskandar, M.; et al. BMI in relation to sperm count: An updated systematic review and collaborative meta-analysis. Hum. Reprod. Update 2013, 19, 221–231. [Google Scholar] [CrossRef]
  141. Cole, A.M.; Ganz, T.; Liese, A.M.; Burdick, M.D.; Liu, L.; Strieter, R.M. Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity. J. Immunol. 2001, 167, 623–627. [Google Scholar] [CrossRef] [Green Version]
  142. Yang, D.; Chen, Q.; Hoover, D.M.; Staley, P.; Tucker, K.D.; Lubkowski, J.; Oppenheim, J.J. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J. Leukoc. Biol. 2003, 74, 448–455. [Google Scholar] [CrossRef]
  143. Hieshima, K.; Ohtani, H.; Shibano, M.; Izawa, D.; Nakayama, T.; Kawasaki, Y.; Shiba, F.; Shiota, M.; Katou, F.; Saito, T.; et al. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 2003, 170, 1452–1461. [Google Scholar] [CrossRef] [Green Version]
  144. Linge, H.M.; Collin, M.; Nordenfelt, P.; Mörgelin, M.; Malmsten, M.; Egesten, A. The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial. Antimicrob. Agents Chemother. 2008, 52, 2599–2607. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  145. Egesten, A.; Eliasson, M.; Johansson, H.M.; Olin, A.I.; Morgelin, M.; Mueller, A.; Pease, J.E.; Frick, I.-M.; Bjorck, L. The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J. Infect. Dis. 2007, 195, 684–693. [Google Scholar] [CrossRef] [Green Version]
  146. Linge, H.M.; Collin, M.; Giwercman, A.; Malm, J.; Bjartell, A.; Egesten, A. The antibacterial chemokine MIG/CXCL9 is constitutively expressed in epithelial cells of the male urogenital tract and is present in seminal plasma. J. Interf. Cytokine Res. Off. J. Int. Soc. Interf. Cytokine Res. 2008, 28, 191–196. [Google Scholar] [CrossRef] [PubMed]
  147. Collin, M.; Linge, H.M.; Bjartell, A.; Giwercman, A.; Malm, J.; Egesten, A. Constitutive expression of the antibacterial CXC chemokine GCP-2/CXCL6 by epithelial cells of the male reproductive tract. J. Reprod. Immunol. 2008, 79, 37–43. [Google Scholar] [CrossRef] [PubMed]
  148. Wuyts, A.; Struyf, S.; Gijsbers, K.; Schutyser, E.; Put, W.; Conings, R.; Lenaerts, J.-P.; Geboes, K.; Opdenakker, G.; Menten, P.; et al. The CXC Chemokine GCP-2/CXCL6 Is Predominantly Induced in Mesenchymal Cells by Interleukin-1beta and Is Down-Regulated by Interferon-gamma: Comparison with Interleukin-8/CXCL8. Lab. Investig. 2003, 83, 23–34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  149. Mine, S.; Nasu, K.; Fukuda, J.; Sun, B.; Miyakawa, I. Secretion of granulocyte chemotactic protein-2 by cultured human endometrial stromal cells. Fertil. Steril. 2003, 79, 146–150. [Google Scholar] [CrossRef]
  150. Fillmore, R.A.; Nelson, S.E.; Lausch, R.N.; Oakes, J.E. Differential Regulation of ENA-78 and GCP-2 Gene Expression in Human Corneal Keratocytes and Epithelial Cells. Investig. Ophthalmol. Vis. Sci. 2003, 44, 3432–3437. [Google Scholar] [CrossRef] [Green Version]
  151. Prause, O.; Laan, M.; Lötvall, J.; Lindén, A. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-α- and interleukin-8 release in human bronchial epithelial cells. Eur. J. Pharmacol. 2003, 462, 193–198. [Google Scholar] [CrossRef]
  152. Gijsbers, K.; Van Assche, G.; Joossens, S.; Struyf, S.; Proost, P.; Rutgeerts, P.; Geboes, K.; Van Damme, J. CXCR1-binding chemokines in inflammatory bowel diseases: Down-regulated IL-8/CXCL8 production by leukocytes in Crohn’s disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue. Eur. J. Immunol. 2004, 34, 1992–2000. [Google Scholar] [CrossRef]
  153. Sachse, F.; Ahlers, F.; Stoll, W.; Rudack, C. Neutrophil chemokines in epithelial inflammatory processes of human tonsils. Clin. Exp. Immunol. 2005, 140, 293–300. [Google Scholar] [CrossRef]
  154. Belardin, L.B.; Légaré, C.; Sullivan, R.; Belleannée, C.; Breton, S. Expression of the pro-inflammatory P2Y14 receptor in the non-vasectomized and vasectomized human epididymis. Andrology 2022, 10, 1522–1539. [Google Scholar] [CrossRef]
  155. Qu, N.; Terayama, H.; Naito, M.; Ogawa, Y.; Hirai, S.; Kitaoka, M.; Yi, S.-Q.; Itoh, M. Caput epididymitis but not orchitis was induced by vasectomy in a murine model of experimental autoimmune orchitis. Reproduction 2008, 135, 859–866. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  156. Turner, T.T.; Mammen, T.; Kavoussi, P.; Lysiak, J.J.; Costabile, R.A. Cytokine Responses to E. coli-induced Epididymitis in the Rat: Blockade by Vasectomy. Urology 2011, 77, 1507.e9–1507.e14. [Google Scholar] [CrossRef]
  157. Tanaka, K.; Fujisawa, M.; Arakawa, S.; Kamidono, S. Local expression of cytokine messenger RNA in rat model of Escherichia coli epididymitis. J. Urol. 1995, 154, 2179–2184. [Google Scholar] [CrossRef] [PubMed]
  158. Cao, D.; Li, Y.; Yang, R.; Wang, Y.; Zhou, Y.; Diao, H.; Zhao, Y.; Zhang, Y.; Lu, J. Lipopolysaccharide-Induced Epididymitis Disrupts Epididymal Beta-Defensin Expression and Inhibits Sperm Motility in Rats1. Biol. Reprod. 2010, 83, 1064–1070. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  159. Veräjänkorva, E.; Pöllänen, P.; Hänninen, A.; Martikainen, M.; Sundström, J.; Antola, H. IL-10 is highly expressed in the cryptorchid cryptepididymal epithelium: A probable mechanism preventing immune responses against autoantigenic spermatozoa in the epididymal tubule. Int. J. Androl. 2002, 25, 129–133. [Google Scholar] [CrossRef]
  160. Watanabe, M.; Kashiwakura, Y.; Kusumi, N.; Tamayose, K.; Nasu, Y.; Nagai, A.; Shimada, T.; Daida, H.; Kumon, H. Adeno-associated virus-mediated human IL-10 gene transfer suppresses the development of experimental autoimmune orchitis. Gene Ther. 2005, 12, 1126–1132. [Google Scholar] [CrossRef]
  161. Rival, C.; Theas, M.S.; Guazzone, V.A.; Lustig, L. Interleukin-6 and IL-6 receptor cell expression in testis of rats with autoimmune orchitis. J. Reprod. Immunol. 2006, 70, 43–58. [Google Scholar] [CrossRef]
  162. Rosenbaum, J.T.; Angell, E. Paradoxical effects of IL-10 in endotoxin-induced uveitis. J. Immunol. 1995, 155, 4090–4094. [Google Scholar] [CrossRef]
  163. Hill, N.; Sarvetnick, N. Cytokines: Promoters and dampeners of autoimmunity. Curr. Opin. Immunol. 2002, 14, 791–797. [Google Scholar] [CrossRef]
  164. Kaneko, T.; Itoh, M.; Nakamura, Y.; Iimura, A.; Hayashi, S.; Takahashi, K.; Stivala, F.; Bendtzen, K.; Nicoletti, F. Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis. Cytokine 2003, 22, 50–53. [Google Scholar] [CrossRef]
  165. Tokunaga, Y.; Terayama, H.; Naito, M.; Qu, N.; Hirai, S.; Ogawa, Y.; Yi, S.-Q.; Itoh, M. Splenic cytokines in mice immunized with testicular germ cells. Int. J. Androl. 2008, 31, 471–476. [Google Scholar] [CrossRef]
  166. Wheeler, K.; Tardif, S.; Rival, C.; Luu, B.; Bui, E.; del Rio, R.; Teuscher, C.; Sparwasser, T.; Hardy, D.; Tung, K.S.K. Regulatory T cells control tolerogenic versus autoimmune response to sperm in vasectomy. Proc. Natl. Acad. Sci. USA 2011, 108, 7511–7516. [Google Scholar] [CrossRef] [Green Version]
  167. Rival, C.; Wheeler, K.; Jeffrey, S.; Qiao, H.; Luu, B.; Tewalt, E.F.; Engelhard, V.H.; Tardif, S.; Hardy, D.; del Rio, R.; et al. Regulatory T cells and vasectomy. J. Reprod. Immunol. 2013, 100, 66–75. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  168. Haddad Kashani, H.; Moshkdanian, G.; Atlasi, M.A.; Taherian, A.A.; Naderian, H.; Nikzad, H. Expression of galectin-3 as a testis inflammatory marker in vasectomised mice. Cell J. 2013, 15, 11–18. [Google Scholar]
  169. Kwong, C.; Gilman-Sachs, A.; Beaman, K. Tumor-Associated a2 Vacuolar ATPase Acts As a Key Mediator of Cancer-Related Inflammation by Inducing Pro-Tumorigenic Properties in Monocytes. J. Immunol. 2011, 186, 1781–1789. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  170. Jaiswal, M.K.; Mallers, T.M.; Larsen, B.; Kwak-Kim, J.; Chaouat, G.; Gilman-Sachs, A.; Beaman, K.D. V-ATPase upregulation during early pregnancy: A possible link to establishment of an inflammatory response during preimplantation period of pregnancy. Reproduction 2012, 143, 713–725. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  171. Migone, F.F.; Ren, Y.; Cowan, R.G.; Harman, R.M.; Nikitin, A.Y.; Quirk, S.M. Dominant activation of the hedgehog signaling pathway alters development of the female reproductive tract. Genesis 2012, 50, 28–40. [Google Scholar] [CrossRef]
  172. Zhu, C.-F.; Liu, Q.; Zhang, L.; Yuan, H.-X.; Zhen, W.; Zhang, J.-S.; Chen, Z.-J.; Hall, S.H.; French, F.S.; Zhang, Y.-L. RNase9, an Androgen-Dependent Member of the RNase A Family, Is Specifically Expressed in the Rat Epididymis1. Biol. Reprod. 2007, 76, 63–73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  173. Dean, M.; Findlay, G.; Hoopmann, M.; Wu, C.; Maccoss, M.; Swanson, W.; Nachman, M. Identification of ejaculated proteins in the house mouse (Mus domesticus) via isotopic labeling. BMC Genom. 2011, 12, 306. [Google Scholar] [CrossRef] [Green Version]
  174. Gangnuss, S.; Sutton-McDowall, M.L.; Robertson, S.A.; Armstrong, D.T. Seminal Plasma Regulates Corpora Lutea Macrophage Populations During Early Pregnancy in Mice1. Biol. Reprod. 2004, 71, 1135–1141. [Google Scholar] [CrossRef] [Green Version]
  175. Bryan, E.R.; Kollipara, A.; Trim, L.K.; Armitage, C.W.; Carey, A.J.; Mihalas, B.; Redgrove, K.A.; McLaughlin, E.A.; Beagley, K.W. Hematogenous dissemination of Chlamydia muridarum from the urethra in macrophages causes testicular infection and sperm DNA damage. Biol. Reprod. 2019, 101, 748–759. [Google Scholar] [CrossRef]
  176. Hazar, A.I.; Cakiroglu, B.; Sakalli, E.; Balci, M.B.C.; Eyyupoglu, E.; Tas, T.; Sinanoglu, O.; Tuzlali, P.; Cilesiz, N.C. The histology and the proapoptotic control in the ipsilateral and the contralateral testes following unilateral vasectomy. Arch. Ital. Urol. Androl. 2015, 87, 198–203. [Google Scholar] [CrossRef]
  177. Monteiro, C.; Marques, P.I.; Cavadas, B.; Damião, I.; Almeida, V.; Barros, N.; Barros, A.; Carvalho, F.; Gomes, S.; Seixas, S. Characterization of microbiota in male infertility cases uncovers differences in seminal hyperviscosity and oligoasthenoteratozoospermia possibly correlated with increased prevalence of infectious bacteria. Am. J. Reprod. Immunol. 2018, 79, e12838. [Google Scholar] [CrossRef] [PubMed]
  178. Hou, D.; Zhou, X.; Zhong, X.; Settles, M.L.; Herring, J.; Wang, L.; Abdo, Z.; Forney, L.J.; Xu, C. Microbiota of the seminal fluid from healthy and infertile men. Fertil. Steril. 2013, 100, 1261–1269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  179. Chen, H.; Luo, T.; Chen, T.; Wang, G. Seminal bacterial composition in patients with obstructive and non-obstructive azoospermia. Exp. Ther. Med. 2018, 15, 2884–2890. [Google Scholar] [CrossRef] [Green Version]
  180. Baud, D.; Pattaroni, C.; Vulliemoz, N.; Castella, V.; Marsland, B.J.; Stojanov, M. Sperm Microbiota and Its Impact on Semen Parameters. Front. Microbiol. 2019, 10, 234. [Google Scholar] [CrossRef] [Green Version]
  181. Bajic, P.; Van Kuiken, M.E.; Burge, B.K.; Kirshenbaum, E.J.; Joyce, C.J.; Wolfe, A.J.; Branch, J.D.; Bresler, L.; Farooq, A. V Male Bladder Microbiome Relates to Lower Urinary Tract Symptoms. Eur. Urol. Focus 2020, 6, 376–382. [Google Scholar] [CrossRef]
  182. Nelson, D.E.; Dong, Q.; Van Der Pol, B.; Toh, E.; Fan, B.; Katz, B.P.; Mi, D.; Rong, R.; Weinstock, G.M.; Sodergren, E.; et al. Bacterial Communities of the Coronal Sulcus and Distal Urethra of Adolescent Males. PLoS ONE 2012, 7, e36298. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  183. Pearce, M.M.; Hilt, E.E.; Rosenfeld, A.B.; Zilliox, M.J.; Thomas-White, K.; Fok, C.; Kliethermes, S.; Schreckenberger, P.C.; Brubaker, L.; Gai, X.; et al. The Female Urinary Microbiome: A Comparison of Women with and without Urgency Urinary Incontinence. MBio 2014, 5, e01283-14. [Google Scholar] [CrossRef] [Green Version]
  184. Thomas-White, K.; Forster, S.C.; Kumar, N.; Van Kuiken, M.; Putonti, C.; Stares, M.D.; Hilt, E.E.; Price, T.K.; Wolfe, A.J.; Lawley, T.D. Culturing of female bladder bacteria reveals an interconnected urogenital microbiota. Nat. Commun. 2018, 9, 1557. [Google Scholar] [CrossRef] [Green Version]
  185. Alfano, M.; Ferrarese, R.; Locatelli, I.; Ventimiglia, E.; Ippolito, S.; Gallina, P.; Cesana, D.; Canducci, F.; Pagliardini, L.; Viganò, P.; et al. Testicular microbiome in azoospermic men—First evidence of the impact of an altered microenvironment. Hum. Reprod. 2018, 33, 1212–1217. [Google Scholar] [CrossRef]
  186. Weng, S.-L.; Chiu, C.-M.; Lin, F.-M.; Huang, W.-C.; Liang, C.; Yang, T.; Yang, T.-L.; Liu, C.-Y.; Wu, W.-Y.; Chang, Y.-A.; et al. Bacterial Communities in Semen from Men of Infertile Couples: Metagenomic Sequencing Reveals Relationships of Seminal Microbiota to Semen Quality. PLoS ONE 2014, 9, e110152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  187. Suarez Arbelaez, M.C.; Israeli, J.M.; Tipton, C.D.; Loloi, J.; Deebel, N.; Leong, J.Y.; Ramasamy, R. Pilot Study: Next-generation Sequencing of the Semen Microbiome in Vasectomized Versus Nonvasectomized Men. Eur. Urol. Focus 2022, 9, 75–82. [Google Scholar] [CrossRef]
  188. Mändar, R.; Punab, M.; Korrovits, P.; Türk, S.; Ausmees, K.; Lapp, E.; Preem, J.-K.; Oopkaup, K.; Salumets, A.; Truu, J. Seminal microbiome in men with and without prostatitis. Int. J. Urol. 2017, 24, 211–216. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  189. Lladó Fernández, S.; Větrovský, T.; Baldrian, P. The concept of operational taxonomic units revisited: Genomes of bacteria that are regarded as closely related are often highly dissimilar. Folia Microbiol. 2019, 64, 19–23. [Google Scholar] [CrossRef] [PubMed]
  190. Kiessling, A.A.; Desmarais, B.M.; Yin, H.-Z.; Loverde, J.; Eyre, R.C. Detection and identification of bacterial DNA in semen. Fertil. Steril. 2008, 90, 1744–1756. [Google Scholar] [CrossRef]
  191. Graham, M.E.; Jelin, A.; Hoon, A.H., Jr.; Wilms Floet, A.M.; Levey, E.; Graham, E.M. Assisted reproductive technology: Short- and long-term outcomes. Dev. Med. Child Neurol. 2023, 65, 38–49. [Google Scholar] [CrossRef]
  192. Jain, M.; Singh, M. Assisted Reproductive Technology (ART) Techniques. In StatPearls [Internet]; StatPearls: Treasure Island, FL, USA, 2023. [Google Scholar]
  193. Marinaro, J.; Goldstein, M. Microsurgical Management of Male Infertility: Compelling Evidence That Collaboration with Qualified Male Reproductive Urologists Enhances Assisted Reproductive Technology (ART) Outcomes. J. Clin. Med. 2022, 11, 4593. [Google Scholar] [CrossRef]
  194. Hanson, B.M.; Kaser, D.J.; Franasiak, J.M. Male Infertility and the Future of In Vitro Fertilization. Urol. Clin. N. Am. 2020, 47, 257–270. [Google Scholar] [CrossRef]
  195. Coward, R.M.; Mills, J.N. A step-by-step guide to office-based sperm retrieval for obstructive azoospermia. Transl. Androl. Urol. 2017, 6, 730–744. [Google Scholar] [CrossRef] [Green Version]
  196. Kresch, E.; Efimenko, I.; Gonzalez, D.; Rizk, P.J.; Ramasamy, R. Novel methods to enhance surgical sperm retrieval: A systematic review. Arab J. Urol. 2021, 19, 227–237. [Google Scholar] [CrossRef]
  197. Punjani, N.; Kang, C.; Schlegel, P.N. Two Decades from the Introduction of Microdissection Testicular Sperm Extraction: How This Surgical Technique Has Improved the Management of NOA. J. Clin. Med. 2021, 10, 1374. [Google Scholar] [CrossRef] [PubMed]
  198. Saade, R.; Neves, P.; Glina, S.; D’Ancona, C.; Dambros, M.; Lúcio, M. Quantitative (Stereological) and Qualitative Study of Rat Epididymis After Vasectomy and Percutaneous Epididymal Sperm Aspiration. J. Urol. 2008, 179, 381–384. [Google Scholar] [CrossRef] [PubMed]
  199. Chung, J.H.; Chung, Y.; Cha, Y.J.; Park, S.Y.; Moon, H.S.; Kim, Y.T.; Choi, H.Y.; Han, D.H.; Jeon, S.S.; Lee, S.W. Anti-adhesion agent to prevent of post-operative adhesion and fibrosis after vasectomy: A study using a rat model. Transl. Androl. Urol. 2022, 11, 1234–1244. [Google Scholar] [CrossRef]
  200. Simons, C.; Deyoung, B.; Griffith, T.; Ratliff, T.; Jones, E.; Mallapragada, S.; Wald, M. Early microrecanalization of vas deferens following biodegradable graft implantation in bilaterally vasectomized rats. Asian J. Androl. 2009, 11, 373–378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  201. Lavers, A.E.; Swanlund, D.J.; Hunter, B.A.; Tran, M.L.; Pryor, J.L.; Roberts, K.P. Acute Effect of Vasectomy on the Function of the Rat Epididymal Epithelium and Vas Deferens. J. Androl. 2006, 27, 826–836. [Google Scholar] [CrossRef]
  202. Chapin, R.E.; Winton, T.R.; Nowland, W.S.; Kumpf, S.W.; Davenport, S.; Karanian, D.; Streck, R.D.; Coskran, T.M.; Barbacci-Tobin, E.G.; Houle, C.; et al. Primary Cell Cultures for Understanding Rat Epididymal Inflammation. Birth Defects Res. Part B Dev. Reprod. Toxicol. 2014, 101, 325–332. [Google Scholar] [CrossRef]
  203. Tait, C.M.; McGinn, J.S.; Milne, E.W.; Bennett, N.K.; McDonald, S.W. Macrophages of the sperm granuloma 3 months after vasectomy in the Albino Swiss rat. Clin. Anat. 2000, 13, 267–276. [Google Scholar] [CrossRef]
  204. van Wely, M.; Barbey, N.; Meissner, A.; Repping, S.; Silber, S.J. Live birth rates after MESA or TESE in men with obstructive azoospermia: Is there a difference? Hum. Reprod. 2015, 30, 761–766. [Google Scholar] [CrossRef] [Green Version]
  205. Hibi, H.; Sumitomo, M.; Fukunaga, N.; Sonohara, M.; Asada, Y. Superior clinical pregnancy rates after microsurgical epididymal sperm aspiration. Reprod. Med. Biol. 2018, 17, 59–63. [Google Scholar] [CrossRef] [Green Version]
  206. Tanaka, A.; Watanabe, S. How to improve the clinical outcome of round spermatid injection (ROSI) into the oocyte: Correction of epigenetic abnormalities. Reprod. Med. Biol. 2023, 22, e12503. [Google Scholar] [CrossRef]
  207. Tekayev, M.; Vuruskan, A.K. Clinical values and advances in round spermatid injection (ROSI). Reprod. Biol. 2021, 21, 100530. [Google Scholar] [CrossRef]
  208. Tao, Y. Oocyte activation during round spermatid injection: State of the art. Reprod. Biomed. Online 2022, 45, 211–218. [Google Scholar] [CrossRef]
  209. McVicar, C.M.; O’Neill, D.A.; McClure, N.; Clements, B.; McCullough, S.; Lewis, S.E.M. Effects of vasectomy on spermatogenesis and fertility outcome after testicular sperm extraction combined with ICSI. Hum. Reprod. 2005, 20, 2795–2800. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  210. Pühse, G.; Hense, J.; Bergmann, M.; Kliesch, S. Bilateral histological evaluation of exocrine testicular function in men with obstructive azoospermia: Condition of spermatogenesis and andrological implications? Hum. Reprod. 2011, 26, 2606–2612. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  211. Allameh, F.; Hosseini, J.; Qashqai, H.; Mazaherylaghab, H. Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial. Int. J. Fertil. Steril. 2019, 13, 240–244. [Google Scholar] [CrossRef]
  212. DuPre, N.C.; Flavin, R.; Sfanos, K.S.; Unger, R.H.; To, S.; Gazeeva, E.; Fiorentino, M.; De Marzo, A.M.; Rider, J.R.; Mucci, L.A.; et al. Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors. Prostate 2018, 78, 1172–1180. [Google Scholar] [CrossRef]
  213. Coady, S.A.; Sharrett, A.R.; Zheng, Z.-J.; Evans, G.W.; Heiss, G. Vasectomy, inflammation, atherosclerosis and long-term followup for cardiovascular diseases: No associations in the atherosclerosis risk in communities study. J. Urol. 2002, 167, 204–207. [Google Scholar] [CrossRef] [PubMed]
  214. Marconi, M.; Pilatz, A.; Wagenlehner, F.; Diemer, T.; Weidner, W. Are antisperm antibodies really associated with proven chronic inflammatory and infectious diseases of the male reproductive tract? Eur. Urol. 2009, 56, 708–715. [Google Scholar] [CrossRef] [PubMed]
  215. Marconi, M.; Nowotny, A.; Pantke, P.; Diemer, T.; Weidner, W. Antisperm antibodies detected by mixed agglutination reaction and immunobead test are not associated with chronic inflammation and infection of the seminal tract. Andrologia 2008, 40, 227–234. [Google Scholar] [CrossRef] [PubMed]
  216. Asadi, N.; Bahmani, M.; Kheradmand, A.; Rafieian-Kopaei, M. The Impact of Oxidative Stress on Testicular Function and the Role of Antioxidants in Improving it: A Review. J. Clin. Diagn. Res. 2017, 11, IE01–IE05. [Google Scholar] [CrossRef]
  217. Jensen, C.F.S.; Østergren, P.; Dupree, J.M.; Ohl, D.A.; Sønksen, J.; Fode, M. Varicocele and male infertility. Nat. Rev. Urol. 2017, 14, 523–533. [Google Scholar] [CrossRef]
  218. Wang, N.N.; Dallas, K.; Li, S.; Baker, L.; Eisenberg, M.L. The association between varicocoeles and vascular disease: An analysis of U.S. claims data. Andrology 2018, 6, 99–103. [Google Scholar] [CrossRef] [Green Version]
  219. Gual-Frau, J.; Abad, C.; Amengual, M.J.; Hannaoui, N.; Checa, M.A.; Ribas-Maynou, J.; Lozano, I.; Nikolaou, A.; Benet, J.; García-Peiró, A.; et al. Oral antioxidant treatment partly improves integrity of human sperm DNA in infertile grade I varicocele patients. Hum. Fertil. 2015, 18, 225–229. [Google Scholar] [CrossRef]
  220. Wang, H.; Lv, Y.; Hu, K.; Feng, T.; Jin, Y.; Wang, Y.; Huang, Y.; Chen, B. Seminal plasma leptin and spermatozoon apoptosis in patients with varicocele and leucocytospermia. Andrologia 2015, 47, 655–661. [Google Scholar] [CrossRef]
  221. Wang, Y.-J.; Zhang, R.-Q.; Lin, Y.-J.; Zhang, R.-G.; Zhang, W.-L. Relationship between varicocele and sperm DNA damage and the effect of varicocele repair: A meta-analysis. Reprod. Biomed. Online 2012, 25, 307–314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  222. Tharakan, T.; Bettocchi, C.; Carvalho, J.; Corona, G.; Jones, T.H.; Kadioglu, A.; Salamanca, J.I.M.; Serefoglu, E.C.; Verze, P.; Salonia, A.; et al. European Association of Urology Guidelines Panel on Male Sexual and Reproductive Health: A Clinical Consultation Guide on the Indications for Performing Sperm DNA Fragmentation Testing in Men with Infertility and Testicular Sperm Extraction in Nonazoosper. Eur. Urol. Focus 2022, 8, 339–350. [Google Scholar] [CrossRef] [PubMed]
  223. Zhao, J.; Zhang, Q.; Wang, Y.; Li, Y. Whether sperm deoxyribonucleic acid fragmentation has an effect on pregnancy and miscarriage after in vitro fertilization/intracytoplasmic sperm injection: A systematic review and meta-analysis. Fertil. Steril. 2014, 102, 998–1005.e8. [Google Scholar] [CrossRef] [PubMed]
  224. Esteves, S.C.; Zini, A.; Coward, R.M.; Evenson, D.P.; Gosálvez, J.; Lewis, S.E.M.; Sharma, R.; Humaidan, P. Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations. Andrologia 2021, 53, e13874. [Google Scholar] [CrossRef]
  225. Lira Neto, F.T.; Roque, M.; Esteves, S. Effect of varicocelectomy on sperm DNA fragmentation rates in infertile men with clinical varicocele: A systematic review and meta-analysis. Hum. Reprod. 2021, 36, 694. [Google Scholar]
  226. Smit, M.; Wissenburg, O.G.; Romijn, J.C.; Dohle, G.R. Increased Sperm DNA Fragmentation in Patients With Vasectomy Reversal Has No Prognostic Value for Pregnancy Rate. J. Urol. 2010, 183, 662–665. [Google Scholar] [CrossRef]
  227. Hallak, J.; Sharma, R.K.; Pasqualotto, F.F.; Ranganathan, P.; Thomas, A.J., Jr.; Agarwal, A. Creatine kinase as an indicator of sperm quality and maturity in men with oligospermia. Urology 2001, 58, 446–451. [Google Scholar] [CrossRef]
  228. Sönmez, M.G.; Haliloğlu, A.H. Role of varicocele treatment in assisted reproductive technologies. Arab J. Urol. 2018, 16, 188–196. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  229. Pathak, P.; Chandrashekar, A.; Hakky, T.S.; Pastuszak, A.W. Varicocele management in the era of in vitro fertilization/intracytoplasmic sperm injection. Asian J. Androl. 2016, 18, 343–348. [Google Scholar] [CrossRef] [PubMed]
  230. Lundy, S.D.; Sabanegh, E.S. Varicocele management for infertility and pain: A systematic review. Arab J. Urol. 2018, 16, 157–170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Diagram presenting the study percentage per year of publication based on the academic database, keywords, and model category.
Figure 1. Diagram presenting the study percentage per year of publication based on the academic database, keywords, and model category.
Jcm 12 02671 g001
Figure 2. Flowchart diagram presenting the study design with the academic databases(s) searched, keywords applied, and strategy, number of entries, and studies eligible.
Figure 2. Flowchart diagram presenting the study design with the academic databases(s) searched, keywords applied, and strategy, number of entries, and studies eligible.
Jcm 12 02671 g002
Table 1. Stratification of studies per year of publication based on design and allocation of patients with the main results that highlight changes in OS biomarkers in human individuals.
Table 1. Stratification of studies per year of publication based on design and allocation of patients with the main results that highlight changes in OS biomarkers in human individuals.
Total Number of
Patients and
Allocation
TAC
(Trolox
Equivalents)
ROS
Log
(ROS + 1)
(cpm)
SOD
(U/mL)
CAT
(U/mL)
p-ValueMethod of AssessmentYear of
Publication and
Reference
n = 117

n = 12
fertile men
n = 21
azoospermic men
n = 84
nonazoospermic men
--37.0 ± 2.8
v.
37.1 ± 2.4
v.
49.1 ± 1.6 a
369 ± 49
v.
364 ± 30
v.
316 ± 1.9
SOD
0.03 b

CAT
0.35 c
SOD—inhibition of the NBT reduction; absorbance at 545 nm and measurements at 3 to 5 min [57]

CAT—decrease in the concentration of H2O2; absorbance at 630 nm and measurements 10 min after alkalinization [57]
2000

[54]
n = 186

n = 19
controls
n = 77
varicocele
n = 43
vasectomy reversal
n = 36
idiopathic infertility
n = 11
varicocele associated with infection
1653.98 ± 115.29
v.
1173.05 ± 58.07
v.
1532.02 ± 74.24
v.
1014.75 ± 79.22
v.
1026.33 ± 150.32
1.3 ± 0.3
v.
2.2 ± 0.13
v.
2.4 ± 0.17
v.
2.3 ± 0.21
v.
3.2 ± 0.25
--TAC
-
0.0005
0.40
0.0001
0.002

ROS
-
0.006
0.001
0.006
0.0001
ROS—chemiluminescence measurement with a luminometer; measurements for 15 min

TAC—enhanced chemiluminescence assay; measurements for 100 s [73]
2000

[64]
n = 27

n = 16
fertile men
n = 11
post-vasectomy men
--37 ± 10
v.
36 ± 10
389 ± 163
v.
325 ± 119
SOD
0.69 b

CAT
0.22 c
SOD—inhibition of the NBT reduction; absorbance at 545 nm and measurements at 3 to 5 min [57]

CAT—decrease in the concentration of H2O2; absorbance at 630 nm and measurements 10 min after alkalinization [57]
2002

[55]
n = 37

n = 15
healthy donors
n = 22
vasectomy reversal
1,556.4 ± 468.1
v.
1719.8 ± 758.6
1.2 ± 0.7
v.
2.3 ± 0.97
--TAC
0.69

ROS
0.009
ROS—chemiluminescence measurement with a luminometer; measurements for 15 min

TAC—enhanced chemiluminescence assay; measurements for 100 s [71]
2005

[65]
n = 160

n = 114
fertile men
n = 46
subfertile men
-ROS in neat semen d
0.4 v. 1.5

ROS in washed semen d
8.1 v. 116
--ROS in neat semen
<0.0001 e

ROS in washed semen
<0.0001 e
ROS in washed and neat semen—chemiluminescence with a luminometer; measurements for 15 min2007

[66]
n = 47
patients

n = 20
varicocele
n = 10
OA
n = 17
idiopathic oligozoospermia or azoospermia
4-HNEp53—varicocele
<0.01

p53—OA
<0.05
-2007

[78]
n = 144

n = 46
controls
n = 20
≤ 40 years old
n = 78
< 40 years old
-ROS in neat semen d
0.68 v. 0.29 v. 1.51
--A
0.0009 f

B
0.006 f

C
< 0.0001 f
ROS in neat
semen—chemiluminescence with a luminometer; measurements for 15 min
2008

[69]
NBT—nitroblue tetrazolium, a—p < 0.05; Student–Newman–Keuls one-way analysis of variance (ANOVA), b—t-test, c—Mann–Whitney rank-sum test, d—20 x 104 cpm, e—p < 0.05; Mann–Whitney U-test, A—p-value between ≥ 40-year-old fertile men and <40-year-old fertile men, B—p-value between ≥ 40-year-old fertile men and controls, C—p-value between < 40-year-old fertile men and controls, f—Wilcoxon rank sum test.
Table 2. Stratification of studies per year of publication based on design, allocation, and strain with the main results that highlight changes in oxidative stress biomarkers in rats and mice.
Table 2. Stratification of studies per year of publication based on design, allocation, and strain with the main results that highlight changes in oxidative stress biomarkers in rats and mice.
Rats
Number of Experimental Models and AllocationStrainOxidative
Biomarker(s)
p-ValueMethod of AssessmentYear of Publication and
Reference
n = 20

n = 10
vasectomy group
n = 10
sham group
Sprague-Dawleynitrate/nitrite (µmol/g protein)
35.6 ± 3.1 v. 19.3 ± 0.7

TBARS (nmol/g protein)
3.7 ± 0.1 v. 3.1 ± 0.1
nitrate/nitrite
0.001

TBARS
0.001
nitrate/nitrite—absorbance at 540 nm [104]

TBRAS—fluorescence—excitation at 510 nm and emission at 553 nm [105] with modifications from [106,107]
2006

[92]
n = 80

n = 10
controls per group
n = 10
intact rats
n = 10
ligation between caput epididymis and upper pole of the testis
n = 10
ligation to both ends (proximal and distal) after division of vas deferens 2–3 cm from caudal epididymis
n = 10
vas divided 2–3 cm from caudal epididymis and ligation applied only to the proximal end
Sprague-DawleyMDA (µmol/mg protein)

group I
0.38 ± 0.24 v. 0.38 ± 0.07
group II
0.92 ± 0.16 v. 0.47 ± 0.23
group III
0.69 ± 0.02 v. 0.42 ± 0.14
group IV
0.40 ± 0.21 v. 0.38 ± 0.02
<0.05MDA—modified TBA method of [108]; absorbance at 535 nm2011

[94]
n = 56

n = 28
sham group (sham-vasectomy/sham-TL)
n = 28
vasectomy group (vasectomy/TL)
Sprague-DawleyPAB (HK unit)

MDA (mmol/mL)
<0.05PAB—enzymatic reaction—chromogen TMB oxidation
chemical reaction—TMB cation reduction

MDA—fluorescence [109]; absorbance at 530 nm
2012

[93]
Mice
n = 112

n = 56
vasectomy group
n = 56
sham group
KunmingMDA (nmol/mg protein)day 15
<0.05

day 30
<0.01
-2014

[83]
n = 70

n = 20 females
exposed to vasectomized males
n = 20 females
sham group
n = 20 females
full castration
n = 10 females
C57BL/6
Mus musculus
C57BL/6
liver, kidney, heart, and gastroc thiols
-
liver, kidney, heart, and gastroc aconitase
housing partner

thiols

liver
0.895
kidney
0.248
heart
0.524
gastroc
0.724

aconitase

liver
0.487
kidney
0.288
heart
0.729
gastroc
0.469

refuge present/
absent

thiols

liver
0.616
kidney
0.112
heart
0.745
gastroc
0.334

aconitase

liver
0.320
kidney
0.967
heart
0.636
gastroc
0.245
acid-soluble thiols [110]; modified colorimetric method from [111]2019

[103]
TBA—thiobarbituric acid, TMB—tetramethylbenzidine 3, 3′, 5.5′.
Table 3. Stratification of studies per year of publication based on design and allocation of patients with the main results that highlight inflammation in human individuals.
Table 3. Stratification of studies per year of publication based on design and allocation of patients with the main results that highlight inflammation in human individuals.
Total Number of Patients and AllocationInflammatory Biomarkerp-ValueMethod of AssessmentYear of Publication and
Reference
n = 37

n = 15
healthy donors
n = 22
vasectomy reversal
IL-6 (pmol/mL)
109.7 v. 4.4

Log10 (IL-6 + 1)
0.99 ± 0.97 v. 2.1 ± 0.9
IL-6 (pmol/mL)
-

Log10 (IL-6 + 1)
0.007
double-antibody sandwich ELISA; measurement at 410 nm [74]2005

[65]
n = 54

n = 21
normozoospermic men
n = 33
pathozoospermic
IL-6 (pg/mL)
11.9 v. 12.0

Total IL-6 (pg/ejaculate)
47.6 v. 46.4
resistin—elastase
≤0.00001

resistin—IL-6
<0.01
ELISA
resistin—sensitivity—0.9 ng/mL; intra and inter-assay CV below 8.9%
elastase and IL-6—sensitivity—2.0 ng/mL; intra and inter-assay CV below 6.9%
2008

[112]
n = 21

n = 14
fertile men
n = 7
vasectomized men
GCP-2/CXCL60.03ELISA
intra-assay precision 5%
inter-assay reproducibility 7%
2008

[147]
n = 54

n = 27
controls
n = 27
MetS


IL-1α
5.53 v. 5.01
IL-1β
1.36 v. 2.40
IL-6
14.93 v. 13.95
IL-12p70
0.95 v. 0.00
TNF-α
1.65 v. 1.23
IFN-γ
3.13 v. 0.00
IL-2
0.51 v. 0.00
IL-4
0.05 v. 0.00
IL-5
3.83 v. 7.54
IL-7
463.98 v. 378.76
IL-9
1.68 v. 0.00
IL-10
0.92 v. 0.96
IL-13
0.025 v. 0.00
IL-17A
0.19 v. 0.00
VEGF
325.16 v. 302.33
FGF
4.38 v. 0.00
GCSF
5.16 v. 2.69
GMCSF
1.34 v. 0.66
Granzyme A
6.92 v. 8.343
MCP-1
8582.33 v. 5090.51
MIP-1α
4.42 v. 1.90
MIP-1β
77.78 v. 44.40
RANTES
125.68 v. 99.03
Eotaxin
41.81 v. 30.17
IL-8
2300.30 v. 1538.18
MIG
10503.09 vs 4407.00
IP-10
10201.11 vs 2160.75
I-TAC
4390.74 vs 4608.28
FKN
154.80 vs 170.80


IL-1α
0.872
IL-1β
0.786
IL-6
0.680
IL-12p70
0.763
TNF-α
0.338
IFN-γ
0.420
IL-2
0.577
IL-4
0.404
IL-5
0.580
IL-7
0.137
IL-9
0.632
IL-10
0.691
IL-13
0.403
IL-17A
0.150
VEGF
0.904
FGF
0.349
GCSF
0.374
GMCSF
0.303
Granzyme A
0.830
MCP-1
0.243
MIP-1α
0.396
MIP-1β
0.159
RANTES
0.387
Eotaxin
0.185
IL-8
0.345
MIG
0.016 a
IP-10
0.012 a
I-TAC
0.951
FKN
0.736
CBA
LLOD
1.0

2.3

1.6

0.6

0.7

1.8

11.2

1.4

1.1

0.5

3.1

0.13

0.6

0.3

4.5

3.4

1.6

0.2

3.7

1.3

0.2

0.8

0.002

0.8

1.2

1.1

0.5

9.1

22.3
2017

[121]
*2022

[154]
ELISA—enzyme-linked immunosorbent assay, CV—coefficients of variation, CBA—cytometric bead array, LLOD—lower limit of detection, IL-1α—interleukin-1α, IL-1β—interleukin-1β, IL-12p70—interleukin-12p70, IFN-γ—interferon-γ, IL-2—interleukin-2, IL-4—interleukin-4, IL-5—interleukin-5, IL-7—interleukin-7, IL-9—interleukin-9, IL-13—interleukin-13, IL-17A—interleukin-17A, FGF—fibroblast growth factor, GCSF—granulocyte colony-stimulating factor, GMCSF—granulocyte-macrophage colony-stimulating factor, MCP-1—monocyte chemoattractant protein-1, MIP-1α—macrophage inflammatory protein-1α, MIP-1β—macrophage inflammatory protein-1β, RANTES—regulated upon activation, normal T cell expressed and presumably secreted, IL-8—interleukin-8, MIG—monokine induced by γ interferon, IP-10—interferon-γ inducible protein 10kDa, I-TAC—interferon–inducible T cell α chemoattractant, FKN—fractalkine, a—p < 0.05; Mann–Whitney U-test, *—Could not be properly evaluated.
Table 4. Stratification of studies per year of publication based on design, allocation, and strain with the main results that highlight inflammation in rats and mice.
Table 4. Stratification of studies per year of publication based on design, allocation, and strain with the main results that highlight inflammation in rats and mice.
Rats
Number of Experimental Models and AllocationStrainInflammatory Biomarkerp-ValueMethod of AssessmentYear of Publication and
Reference
n = 21

n = 7
bilateral sham vasectomy/unilateral sham inoculation
n = 7
bilateral sham vasectomy/unilateral inoculation of Escherichia coli
n = 7
bilateral vasectomy/unilateral inoculation of Escherichia coli
Sprague-DawleyControls

IL-1α (pg/µL)
53.8–60.0 pg/µL
IL-1β (pg/µL)
78.8–83.6 pg/µL
IL-4 (pg/µL)
232.4–240.0 pg/µL
< 0.05bead-based multiplexed immunoassay2011

[156]
Mice
n = 56

n = 8
untreated group
n = 8
shamVx+PBS group
n = 10
Vx+PBS group
n = 8
shamVx+TGC group
n = 22
Vx+TGC group
A/Jtestis

shamVx+TGC group
IFNγ
IL-10

epididymis

Vx+PBS group
IFNγ
IL-6
IL-10

Vx+TGC group
IL-6
IL-10

all are relative to β-actin
testis
< 0.05

epididymis

Vx+PBS group
< 0.05

Vx+TGC group
< 0.01
mRNA by real-time RT-PCR2008

[155]
n = -

n = -
INT
n = -
SVX
n = -
VAS
BALB/c (H-2 d)capacitated sperm

a2v
Lif
IL-1β
TNF

a2NTD injected horn

Lif
IL-1β
TNF
Ccl2

INT day 4

a2v
Ccl2
Lif
Hoxa 10
-
all are relative to Gapdh
capacited sperm
< 0.01

a2NTD injected horn
< 0.01

INT day 4
a2v, Ccl2
< 0.01
Lif, Hoxa 10
< 0.05
multiplex real-time PCR2012

[170]
n = 20

n = 10
sham group
n = 10
vasectomized
BALB/cGalectin-3--2013

[168]
RT-PCR—real-time polymerase chain reaction, Ccl2—C-C motif chemokine ligand 2, Lif—leukemia inhibitory factor, a2V—a2 vacuolar-ATPase, HOXA 10—homeobox protein hox-A10
Table 5. Leading human semen microbiota studies based on the allocation of patients and platform used for sequencing with the microbial region and oscillations within communities observed in human individuals.
Table 5. Leading human semen microbiota studies based on the allocation of patients and platform used for sequencing with the microbial region and oscillations within communities observed in human individuals.
Total Number of Patients and AllocationHypervariable
Region
SequencerMicrobial RatioYear of PublicationReference
n = 37

n = 25
idiopathic infertility men
n = 12
healthy men
V3-V4MiSeq—IlluminaCollinsella ↓↑
Staphylococcus
Lachnospiraceae
Coprococcus
Anaerococcus ↓↑
2021[53]
n = 58

n = 18
post-vasectomy men
n = 22
fertile non-vasectomized men
n = 18
post-vasectomy men
V12MiSeq—IlluminaSphingomonas
Brevundimonas
Paracoccus
Corynebacterium
2023[187]
↓—decreased, ↑—increased, ↑↓—fluctuations.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Doroftei, B.; Ilie, O.-D.; Maftei, R.; Scripcariu, I.-S.; Armeanu, T.; Stoian, I.-L.; Ilea, C. A Narrative Review Discussing Vasectomy-Related Impact upon the Status of Oxidative Stress and Inflammation Biomarkers and Semen Microbiota. J. Clin. Med. 2023, 12, 2671. https://doi.org/10.3390/jcm12072671

AMA Style

Doroftei B, Ilie O-D, Maftei R, Scripcariu I-S, Armeanu T, Stoian I-L, Ilea C. A Narrative Review Discussing Vasectomy-Related Impact upon the Status of Oxidative Stress and Inflammation Biomarkers and Semen Microbiota. Journal of Clinical Medicine. 2023; 12(7):2671. https://doi.org/10.3390/jcm12072671

Chicago/Turabian Style

Doroftei, Bogdan, Ovidiu-Dumitru Ilie, Radu Maftei, Ioana-Sadyie Scripcariu, Theodora Armeanu, Irina-Liviana Stoian, and Ciprian Ilea. 2023. "A Narrative Review Discussing Vasectomy-Related Impact upon the Status of Oxidative Stress and Inflammation Biomarkers and Semen Microbiota" Journal of Clinical Medicine 12, no. 7: 2671. https://doi.org/10.3390/jcm12072671

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop